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Anxiety and social withdrawal often emerge during Alzheimer’s disease (AD); 
investigating their neurobiological underpinnings is thus important. To this end, we 
examined social and anxiety-related behaviours in male and female AppNL-F and   
AppNL-G-F mice aged 8 and 15-months, and characterized the microstructural integrity of 
neural tissue using ex vivo diffusion tensor imaging. These novel APP knock-in mice 
have translational advantages given that they model Aβ pathology without the 
overexpression of APP. The AppNL-G-F mice exhibit a threefold-faster Aβ deposition 
compared to the AppNL-F mice: this provides the added opportunity to explore the 
differential effects of soluble Aβ oligomers and insoluble fibrillar Aβ on behaviour and 
its neural substrates. Using the Crawley 3-chamber protocol, preference for sociability 
in the 8 and 15-month old AppNL-F and AppNL-G-F mice was intact. A mild impairment in 
preference for social novelty in the 8-month old AppNL-F and AppNL-G-F mice, as well as a 
mild social olfaction deficit in the 8-month old female AppNL-G-F mice and the 15-month 
old AppNL-F and AppNL-G-F mice, was observed. Regarding the anxiety assessing tasks, 
both the 8 and 15-month old AppNL-F mice displayed unaltered behaviour in the open 
field and elevated plus-maze; in contrast, the 8-month old AppNL-G-F mice combined an 
ostensibly anxiogenic open field profile with an ostensibly anxiolytic plus-maze profile. 
This ostensibly anxiolytic plus-maze profile persisted in the 15-month old AppNL-G-F 
mice. Together, these results suggest that the AppNL-G-F mouse may enable modeling of 
the neurobiological links between emergent disinhibition-type behaviour and AD. 
Consistent with this suggestion, notable microstructural alterations were observed in 
the orbitofrontal and anterior cingulate cortices of both the younger and older AppNL-G-F 
mice. Microstructural alterations did not emerge in the AppNL-F mice until the later age 
point. Insoluble Aβ likely contributes to the behavioural and neuropathological 
characteristics seen in the AppNL-G-F, but not the AppNL-F, mice.  
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CHAPTER - 1 
INTRODUCTION 
 
1.1 Alzheimer’s disease: prevalence and impact 
Alzheimer’s disease (AD) is the leading cause of dementia in the elderly (≥ 65 years), 
and a significant international health-care burden. Approximately two-thirds of the 
estimated 48-million dementia cases worldwide are attributed to AD (Prince et al., 
2015), and by 2050 the number of people living with AD is projected to triple due 
mainly to the increase in global life expectancy (Livingston et al., 2017). Despite 
intensive efforts by the scientific community to establish therapeutics that are capable 
of altering the course of this chronic and progressive neurodegenerative illness, there 
are no forthcoming treatments that can cure or prevent the disease from developing 
(Mehta et al., 2017; Cummings et al., 2016). The insidious onset of neurodegeneration 
that occurs in AD, initially within the medial temporal structures and ultimately 
throughout the cerebral cortex (Delacourte et al., 1999; Braak & Braak, 1991; Hyman et 
al., 1984), leaves patients unable to care for themselves, and the effect of this on the 
patients, caregivers and societies-at-large cannot be overstated (Winblad et al., 2016). It 
is predicted that by 2060 ‘AD and other dementias’ will be the third leading cause of 
death globally and the most common cause of death in high-income nations (World 
Health Organization, 2018). In response to these issues, AD has been declared one of 
the great health-care challenges of the century (Nichols et al., 2019; Scheltens et al., 
2016) as researchers strive toward new ways of identifying individuals who are at-risk 
of developing AD with the aim to improve quality of life and importantly, establish 
therapeutics that can act prior to any substantial neurological change.  
 
1.2 Neuropsychiatric symptoms as an early sign of emerging Alzheimer’s disease 
AD has long been characterized clinically as a disorder of cognition resulting in 
symptoms such as episodic memory loss, executive dysfunction, visuospatial deficits 
and topographical disorientation yet these cognitive changes represent only one aspect 
of the behavioural alterations that are known to manifest in the disease. 
Neuropsychiatric symptoms (NPS) are nearly universal in AD (McKhann et al., 2011), 
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and are known to occur more frequently in people with the disease than in the general 
population (Lyketsos et al., 2011). NPS can be delineated into five categories (Ismail et 
al., 2016) to describe changes in affect (e.g., anxiety and depression), motivation (e.g., 
apathy and indifference), impulse control (e.g., disinhibition and agitation), perception 
(e.g., delusions and hallucinations) and social appropriateness (e.g., loss of tact). 
According to Steinberg et al. (2008), Lyketsos et al. (2002) and Mega et al. (1996) an 
estimated 80-97% of AD patients will experience at least one NPS over the duration of 
the disease. Furthermore, the presence of NPS in AD has been associated with a range 
of adverse effects, such as greater levels of patient-family dysfunction and caregiver 
distress (Storti et al., 2016; Fischer, Ismail & Schweizer, 2012; Allegri et al., 2006), 
impaired quality of life for patients and their caregivers (Hongisto et al, 2018; Shin et 
al., 2005), hastened functional decline (You et al., 2015; Mortimer et al., 1992) and 
higher rates of placement in residential care (Voisin et al., 2010; Gilley et al., 2004). As a 
result, investigating the occurrence of NPS in mild cognitive impairment (MCI) is 
relevant. MCI confers a risk of AD, and is recognized as the earliest symptomatic stage 
of the disease. It is a heterogeneous entity whereby 5-15% of cases will evolve to 
identifiable AD (Albert et al., 2011).  
 
There is substantial evidence to demonstrate that NPS are highly prevalent in MCI. For 
example, an early informative study by Hwang et al. (2004) found that there were 
significant differences in the prevalence of NPS between individuals with MCI and 
matched controls. Apathy (39%) and anxiety (25%) were amongst the two most 
common disturbances reported by people with MCI, with apathy being particular 
common in amnestic MCI (aMCI), the most empirically validated precursor to AD. 
Similar results have been reported in large population-based studies. For instance, 
Geda et al. (2008) found that individuals with MCI were significantly more likely to 
report having one or more NPS (51%) compared to people with normal cognitive 
ageing (27%). Taking into account the odds ratio (OR) and frequency of a symptom, the 
authors identified apathy (OR, 4.53; p < 0.001) and anxiety (OR, 3.00; p < 0.001) as the 
first and third most distinctive features (respectively) between the two groups. 
Moreover, apathy was higher in aMCI than non-amnestic MCI. Similarly, in a 
population-based study by Peters et al. (2012), participants with MCI were twice          
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as likely (31%) to report at least one NPS compared to the participants who were 
cognitively normal (15.1%), yet less likely compared to the participants with AD 
dementia (61%). Apathy and anxiety were amongst the most frequently reported 
symptoms in MCI, as well as aMCI and AD dementia; both were associated with a 
significant upward trend in prevalence (cognitively normal ≤ MCI or aMCI ≤ AD). As 
such, researchers have examined whether comorbid presentation of NPS and MCI   
confers a greater risk for developing AD.  
 
There is evidence that the presence of NPS in MCI increases the risk of AD dementia. In 
a longitudinal study of MCI patients, Rosenberg et al. (2013) found that the co-morbid 
presentation of NPS with MCI resulted in a clinically significant risk of progression 
from MCI to AD; however, whether NPS were a prodrome of the neuropathological 
process of AD is unclear without biomarker evidence. Similarly, Peters et al. (2013) 
followed 230 MCI patients over a 3-year period and found that NPS constituted a 
significant risk of transition to AD dementia. The perspective of NPS as a harbinger of 
AD has existed for at least twenty years (e.g., Chung & Cummings, 2000; Berger et al., 
1999). However, attention to NPS in AD is growing as researchers become more aware 
of the need to identify individuals at-risk for AD prior to any substantial cognitive 
decline (Dubois et al., 2016). As a result, Ismail et al. (2016) proposed the diagnostic 
construct of mild behavioural impairment (MBI) to describe the late-life emergence (≥ 
50 years) of sustained and impactful affective and behavioural change as a prodromal 
feature of AD. MBI is conceptualized to occur prior to or in tandem with the initial 
signs of AD-related cognitive decline.  
 
Most recently Wise et al. (2019) demonstrated that the late-life emergence of NPS could 
signal impending AD, and that NPS can manifest prior to AD-related cognitive 
symptoms. In this prospective cohort study of cognitively normal individuals (≥ 60 
years) with no prior history of psychiatric disorder, 59% of the 1,998 participants who 
developed a cognitive disorder during the course of the study reported the occurrence 
of NPS prior to a cognitive diagnosis. In contrast, of the 3,124 participants who 
remained free from a cognitive diagnosis only 24.5% reported an occurrence of NPS. 
With regard to the 392 participants who received a specific diagnosis of AD, NPS 
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preceded the diagnosis of MCI in 30% of the participants, and an additional 42% of the 
participants developed NPS between the diagnosis of MCI and AD dementia; 12% 
reported no NPS and 17% reported NPS after the diagnosis of AD dementia. 
Additionally, there were 1,032 participants who were diagnosed with aMCI during the 
course of the study, of which 54% developed NPS before the aMCI diagnosis and a 
further 24% developed NPS either after the aMCI diagnosis or before dementia (for 
those who progress from normal to dementia). This is a key study that supports the 
MBI construct, and demonstrates that emergent NPS are indeed associated with future 
AD-related cognitive decline as opposed to ageing per se. It also indicates a rationale 
for investigating anxiety and social withdrawal as early emergent symptoms of AD. 
Anxiety was amongst the most common NPS to emerge prior to MCI, and also between 
the diagnosis of MCI and dementia onset. It was also common for apathy to manifest 
before and after dementia, albeit somewhat less common to manifest prior to MCI.  
 
1.3 Increased anxiety and reduced social engagement in Alzheimer’s disease 
In reiteration of the previously cited literature, anxiety is a common feature of MCI 
(Apostolova & Cummings, 2008). In some studies up to 71% of AD patients reported 
anxiety concerns (Ferretti et al., 2001). Furthermore, the co-occurrence of anxiety with 
MCI has been associated with an increased risk of AD dementia (Mah et al., 2015). 
Moreover, in a study by Palmer et al. (2007), of the MCI patients who also displayed 
anxiety symptoms, 83.3% developed AD over the 3-year time point as opposed to 
40.9% who had MCI without anxiety. Furthermore, Pietrzak et al. (2015) studied 
healthy older adults with elevated Aβ levels and found that those who also had anxiety 
symptoms experienced greater cognitive decline. Thus, anxiety appears to be an early 
feature of AD that has a mediating effect on clinical outcomes.  
 
Early AD-related neurodegenerative changes may explain the increase in anxiety. 
Donovan et al. (2018) and Hanseeuw et al. (2018) investigated the relationship between 
brain Aβ plaque burden, as determined by PiB-PET (Pittsburgh Compound B Positron 
Emission Tomography), and anxiety in cognitively normal community dwelling 
individuals aged 62 to 90 years. Donovan et al. (2018) assessed participants (n=270) 
longitudinally and found that higher baseline Aβ burden was significantly associated 
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with worsening anxiety symptoms over time. Hanseew et al. (2018) investigated 
participants (n=188) at a single time point and found that higher subcortical Aβ burden 
was significantly associated with greater self-report measures of anxiety; there was no 
association when assessing cortical Aβ burden which precedes subcortical Aβ 
deposition. Moreover, anxiety was highest in APOEε4 carriers (individuals at risk of 
AD) with subcortical amyloidosis. Donovan et al. (2018) and Hanseeuw et al. (2018) 
replicated the findings in Holmes et al. (2016). Based on the participants’ increased 
levels of Aβ they were likely to have tau accumulation and neurodegeneration that 
may have mediated the relationship to anxiety. Ramakers et al. (2013) found that the 
presence of anxiety in MCI patients was associated with abnormal cerebrospinal fluid 
(CSF) Aβ42  [OR 2.3, 95% CI 1.6–3.3] and CSF total tau [OR 2.6, 95% CI 1.9–3.6], and an 
abnormal ratio of Aβ42 and total tau [OR 3.1, 95% CI 2.0–4.7]. These are biomarkers of 
AD that signal neurodegeneration and predict the progression from MCI to AD.  
 
Social withdrawal is an equally common and debilitating behavioural change in AD 
(Feldman et al., 2004; Doody et al., 1995). It refers to an individual’s withdrawal from 
their social networks as well as a loss of interest in previously enjoyed social activities. 
Social withdrawal as a clearly defined phenotype of AD has yet to be well studied; 
however, the previously cited literature on apathy is relevant to an extent based on 
shared behavioural features such as a reduced motivation to engage. There is evidence 
to suggest that social withdrawal may signal the onset of AD. In a retrospective review 
of medical records of 100 randomly selected autopsy-confirmed AD patients, Jost and 
Grossberg (1996) found that social withdrawal was present in 40% of patients as well as 
it being the earliest recognizable NPS to be reported based on patient and caregiver 
accounts. In some instances social withdrawal was present up to five years prior to a 
diagnosis of cognitive disorder. Similarly, a retrospective review by Barnes et al. (2015) 
of the National Alzheimer’s Coordinating Center (NACC) dataset (Beekly et al., 2007) 
found that ‘apathy/social withdrawal’ was the first and second most commonly 
reported initial behavioural symptom depending on the age of the person at the time of 
diagnosis; ≥ 70 years (5,894; 26%) and ≤ 69 years (1,921; 25%), respectively. 
Furthermore, social withdrawal may exacerbate the risk of developing dementia.  
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Remaining socially active in later life has been identified as a potential protective factor 
against dementia (Fratiglioni, Paillard-Borg & Windblad, 2004). In a longitudinal study 
of community dwelling residents aged 65 years and older, Scarmeas et al. (2001) found 
that those with higher levels of social interaction had a significantly reduced risk of 
cognitive decline and dementia. This finding was supported in a meta-analysis of 
longitudinal cohort studies (Kuiper et al., 2015); however, Brown et al. (2012) found 
inconclusive evidence in a smaller, but similar systematic review. In a recent Lancet 
Commission Report, social isolation was found to constitute 2.3% of the total risk for 
developing AD (Livingston et al., 2017). The size of one’s social network may also 
influence cognitive health. For example, having a larger social network was associated 
with lower risk of dementia over a 4-year follow up of cognitively normal, community-
dwelling elderly women (Crooks, et al., 2008), and Bennett et al. (2016) found that AD 
patients with larger social networks experienced slower cognitive decline compared to 
AD patients with small social networks. Moreover, elderly people who identify as 
lonely have nearly double the risk of developing AD (Wilson et al., 2017); however, 
subjective feelings of loneliness are not necessarily the same as objective measures of 
social withdrawal (Cacioppo et al., 2015). Together, the evidence suggests that social 
withdrawal may be a harbinger of AD and/or impact on the progression of disease. For 
these reasons, understanding social withdrawal in the context of AD has become a 
matter of priority. For example, the PRISM consortium (Cuthbert et al., 2019) is a 
recently established European Union funded research initiative dedicated to 
investigating the neurobiology of social withdrawal in neurological disorders such as 
AD.  
 
Anxiety and reduced social engagement in AD has traditionally been placed within the 
framework of psychiatric nosology, yet it is unclear whether the underlying 
neurobiology of these symptoms differs when in the context of the AD brain (Lanctôt et 
al., 2017; Rosenberg, Nowrangi & Lyketsos, 2015). From the perspective that these 
symptoms are a consequence of AD pathogenesis, it is reasonable to suggest that they 
are based in unique biological pathways which may in part explain why therapeutics 
that are typically prescribed to treat psychiatric illness are ineffective in the AD patient 
(Lanctôt et al., 2017; Rosenberg, Ismail et al., 2016; Nowrangi & Lyketsos, 2015; Geda et 
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al., 2013). Given the prevalence of these symptoms in AD and the range of adverse 
effects associated with their presence in AD, the need to develop effective treatments is 
a matter of urgency. Moreover, given the growing consensus that the late-life 
emergence of anxiety and social withdrawal may constitute harbingers of AD and 
impact on disease progression, treatment of these symptoms may provide potential 
connections to early prevention of AD dementia (Katona et al., 2007). To that end, a 
main objective of this thesis is to probe the microstructural integrity of the neural tissue 
of a new generation of AD model mice using ex vivo diffusion tensor imaging (DTI). 
Indications of neural alteration provide a start point in exploring associated underlying 
altered mechanisms, and in turn, elucidating altered mechanisms is a key stage in the 
drug discovery process. AD-related neural regions that are relevant to changes in 
anxiety and social behaviours remain unclear; however, candidate regions can be 
identified based on the current literature. The following section briefly outlines the 
rationale behind our chosen candidate regions of interest.  
 
1.4 Neuroanatomical correlates of anxiety and social behaviour     
Our candidate regions of interest for DTI were the orbitofrontal cortex, anterior 
cingulate cortex, the amygdala and the dorsal and ventral hippocampus. There is 
consistent evidence to suggest that these neuroanatomical regions mediate anxiety 
behaviours and underlie normal social functioning in rodents as well as humans, and 
in many instances contribute to both anxiety and social behaviours. The role of the 
rodent amygdala in anxiety-like behaviour (a response to perceived threat), and more 
specifically fear (a response to real threat), is well evidenced across laboratories using a 
variety of experimental techniques (Davis, Rainnie & Cassell, 1994). For example, 
stimulation of the amygdala elicits a pattern of anxiogenic behaviour whereas 
amygdalar lesions produce an anxiolytic effect in tests of unconditioned fear (Davis, 
1992). The fear-related neurocircuitry identified in rodents provides a basis for 
understanding the neurocircuitry of anxiety disorder in humans. Its basic elements 
appear well preserved across species and are likely to support similar functions in 
humans. In fact a number of in vivo neuroimaging studies have demonstrated an 
association between anxiety and heightened amygadalar activation in humans (Shin & 
Liberzon, 2010). Adolphs (2010) assigned a slightly broader function to the amygdala 
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as a component in a neural network, including the orbitofrontal cortex, which 
processes the saliency and relevance of stimuli, particularly stimuli that may signal 
unpredictability or potential threat. Thus, the amygdala is additionally viewed as 
having functional implications in social behaviour. Similarly, Davidson (2002) 
highlights evidence across species for the role of the amygdala and orbitofrontal cortex 
(and prefrontal cortex in general) as part of a neural network that mediates affective 
processing and emotional regulation, and governs different aspects of anxiety. 
Moreover, Poulin et al. (2011) and Liu et al. (2010) found neurodegenerative changes in 
the amygdala in MCI patients using volumetric MR imaging, and these changes in 
volumetric MR measurements predicted conversion to AD. 
 
McHugh et al. (2004) demonstrated a specific role for the ventral hippocampus in 
response to anxiogenic stimuli. Rats with cytotoxic ventral hippocampus lesions 
showed reduced anxiety-like behaviour across a number of unconditioned tests of 
anxiety, including a modified version of the elevated plus-maze. This study extended 
the findings of Bannerman et al. (2003) by demonstrating that the anxiolytic effects of 
ventral hippocampus lesions were distinct from the effects of dorsal hippocampus and 
amygdala cytotoxic lesions in unconditioned tests of anxiety. Thus, McHugh et al. 
(2004) propose only a limited role for the amygdala in rodent anxiety and instead link 
the amygdala more specifically to regulating fear responses. The hippocampus has also 
been implicated in social behaviour. For example, in McHugh et al. (2004), the rats with 
ventral hippocampus lesions displayed an increase in social behaviour when allowed 
to freely explore a novel conspecific; this was presumably due to their reduced anxiety. 
Hitti and Siegelbaum (2014) demonstrated that the silencing of mouse dorsal CA2 
pyramidal neurons resulted in a pronounced deficit in preference for social novelty, 
but not sociability, in the Crawley 3-chamber test, and this was presumably due to a 
disruption in sociocognitive memory processing. Okuyama et al. (2016) evidenced a 
role of the ventral CA1 hippocampal region in ability of mice to discriminate a novel 
conspecific from a previously encountered conspecific. The authors concluded that 
vCA1 and dCA2 have a shared, albeit undefined role in sociocognitive processing. 
Moreover, pathology in the hippocampus occurs early in AD, and predicts conversion 
from MCI to AD (Liu et al., 2010; Devanand et al., 2007).  
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Etkin, Egner and Kalisch (2011) review a wealth of data across species that implicates 
the anterior cingulate cortex and medial prefrontal cortex (including orbitofrontal 
cortex) in the processing of anxiety and fear. These authors further highlight the role of 
these regions in an array of socio-emotional processes. Apathy, which is characterized 
in part by social withdrawal (Marshall et al., 2013), is likely to be mediated by a frontal-
subcortical circuit, with particular association to the anterior cingulate cortex (Moretti 
& Signori, 2016; Cummings, 1993). A role for the anterior cingulate cortex and the 
orbitofrontal cortex in apathy in mild to moderate AD was evidenced using functional 
MR imaging (Marshall et al., 2013) as well as structural MR imaging (Bruen et al., 2008). 
Interestingly, in Okello et al. (2009), the anterior cingulate cortex had the highest Aβ 
burden in MCI patients relative to controls, and a higher anterior cingulate Aβ load 
predicted faster conversion from MCI to AD.   
 
As stated previously, an objective of identifying a link between brain anatomy and 
neurodegenerative change is that it provides a basis for investigating the associated 
functional and biochemical alterations that drive anxiety and social withdrawal 
symptoms in AD. A more substantive understanding of these early-altered 
mechanisms may contribute to the future development and testing of novel 
therapeutics. Thus, we aim to capture and characterize a putative neural signature 
associated with anxiety-like behaviours and altered social behaviour in AD mice using 
DTI, which may also address the need of identifying a sensitive imaging marker that 
could help facilitate the detection of MBI cases with an underlying neurodegenerative 
process (Canevelli et al., 2016). Animal models form a crucial component in AD 
research. They allow for the ability to probe more precisely the neuronal circuits 
involved in behavioural change (Calhoon & Tye, 2015; Cryan & Holmes, 2005), and 
record more accurately the spatiotemporal pattern between disease processes and 
pathology. The following section outlines the features of the mouse models that are 
used in this thesis.  
 
1.5 AppNL-F and AppNL-G-F knock-in mice: improved models of Alzheimer’s disease    
Model organisms have been instrumental in AD research, with the most common 
model organism being the laboratory mouse (Mus musculus). The first AD model 
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mouse was generated in 1995 and since that time over 100 genetically engineered 
mouse models have been developed for AD research (Hall & Roberson, 2012). AD 
appears to be a uniquely human disorder. No condition that faithfully recapitulates the 
key clinicopathological aspects of AD has ever been identified in a nonhuman species 
(Platt, Reeves & Murphy, 2013). Some mammals do accumulate Aβ in the brain as they 
age, however, neurofibrillary tangles are rare in these species and the downstream 
effects of aberrant Aβ accumulation (e.g., neuronal loss, dementia-like syndrome) are 
practically non-existent (Gerhauser et al., 2012). The ability to generate AD model 
organisms through genetic manipulation was made possible by the discovery of rare 
hereditary mutations that result in pathologically and clinically proven cases of the 
disease.  
 
Autosomal dominant familial AD (FAD) is a rare form of early onset AD (EOAD)      (≤ 
65 years) caused by a hereditary mutation in one of at least three genes, which code for 
Amyloid Precursor Protein (APP), Presenilin-1 (PSEN1) or Presenilin-2 (PSEN2), all of 
which affect the processing of amyloid-β (Huang & Mucke, 2012; Bateman et al., 2011). 
Sporadic late-onset (≥ 65 years) AD has an unclear aetiology and accounts for more 
than 90% of all cases. Although FAD is responsible for only 1% of the diagnosed 
occurrences of AD, it shares many of the same molecular and clinical features with 
sporadic AD. As a result, mice that are transgenic for FAD mutations have been 
instrumental in identifying pathways implicated in the more common, sporadic form 
of the disease (Elder, Gama Sosa & De Gasperi, 2010). Despite the positive impact these 
models have had on AD research, the conventional technology used to generate them 
has been associated with disadvantages.  
 
The majority of mice used in AD research model Aβ pathology by overexpressing APP. 
The overexpression paradigm has been shown to cause artifacts that may confound 
data interpretation (Saito et al., 2014). To overcome these confounds Saito et al. (2014) 
generated the AppNL-F and AppNL-G-F mice. These mice have humanized Aβ sequences 
with familial mutations in the endogenous APP mouse gene. Mice carrying the 
Swedish (K670N/M671L) and Beyreuther/Iberian (I716F) mutations, termed AppNL-F, 
exhibit an increase in total Aβ levels with an elevated ratio of Aβ42 to Aβ40. Mice 
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carrying the additional Arctic (E693G) mutation, referred to as AppNL-G-F, exhibit a more 
oligomerization-prone Aβ peptide that results in a threefold faster, more aggressive Aβ 
deposition compared to the AppNL-F mice (Saito et al., 2014). Both models typify the 
pathology seen in preclinical AD without APP overexpression or the interruption of 
other mouse genes. However, these models do not develop tauopathy. These models 
are anticipated to have greater translational value, and are also suitable for this thesis 
as they model the initial, preclinical aspects of AD.  
 
1.6 Thesis Aims and Objectives 
There are relatively few studies to date that characterize the behaviour of the AppNL-F 
and AppNL-G-F mice. The first aim was to extend the behavioural profile of these next 
generation APP knock-in mouse lines to investigate for phenotypes analogous to the 
anxiety and social withdrawal symptoms commonly observed in AD. With limited 
insight into the neurobiology underpinning these affective and behavioural anomalies 
in AD patients, it is necessary to find AD mice that reliably model these symptoms, 
particularly mice that more authentically recapitulate the AD pathology expressed in 
humans. Should these model mice have a robustly relevant phenotype they could serve 
as a valuable translational tool in discovering the mechanisms that drive anxiety and 
social withdrawal in people with AD. In addition to promoting basic research on a 
topic that has not yet been fully understood, a practical reason is to assist in the 
translation of new medical treatments aimed at alleviating these symptoms. Since 
mechanisms of action and target engagement are likely to differ in the context of the 
AD brain versus the non-AD brain (Lanctôt et al., 2017; Rosenberg, Nowrangi & 
Lyketsos, 2015; Insel et al., 2010), identifying appropriate AD mice for the development 
and testing of novel therapeutics is an additional necessity. Our first objective was to 
measure the behavioural performance of male and female AppNL-F and AppNL-G-F mice 
using commonly employed tests of rodent emotionality and social interaction, and to 
compare their performance to age-matched APP wild-type control mice. Chapter 2 
provides further details of the behavioural approach.  
The second aim was to explore the microstructure of behaviourally relevant brain 
regions using diffusion tensor imaging (DTI), marking the first study to apply DTI to 
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the AppNL-F and AppNL-G-F mice. In order to capture and characterize any subtle 
instances of neurodegenerative change in the APP knock-in mice, the diffusion tensor 
model was fitted to ex vivo MR images, and diffusion indices were extracted from 
manually drawn a posteriori regions of interest. Given that our wider research initiative 
was to identify putative biological mechanisms driving anxiety and altered social 
behaviour in AD, DTI was used primarily as a means to identify which of the targeted 
brains regions warranted investigating for altered oscillatory activity and gene 
expression. Herein, the DTI approach served to identify microstructural alterations as a 
sort of proof-of-concept study to address a key idea put forth by Canevelli et al. (2016) 
in response to the introduction of the MBI construct by Ismail et al. (2016). Canevelli et 
al (2016) argues for the need of a sensitive imaging marker that could facilitate the 
detection of MBI cases with an underlying neurodegenerative process, for the critical 
reason of preventing false positive diagnoses in preclinical AD trials. DTI may also 
prove useful in the preclinical evaluation of disease-modifying treatments developed to 
act specifically in early AD stages (Wiener et al., 2017). For this latter reason, DTI was 
applied irrespective of the behavioural performance of mice, which is justified given 
that the subtle microstructural alterations captured by DTI can precede overt 
behavioural change (Alexander et al., 2007). Details of the DTI approach are outlined in 
chapter 3.  
Building upon these primary aims was the decision to evaluate behaviour and its 
neuroanatomical correlates in both the AppNL-F and AppNL-G-F models. This study is the 
first to compare the behaviour and neural alterations of the two models beyond the 
original Saito et al. (2014) paper. Explicitly comparing the AppNL-F and AppNL-G-F mice 
will help identify to what extent their differing pathologies may or may not account for 
behavioural or neurological change. Specifically, a comparative analysis of these APP 
knock-in mouse lines allows us to consider the effect and temporal relationship of 
different amyloid-β assemblies on the manifestation and underlying neuropathy of 
neuropsychiatric symptoms (Mucke & Selkoe, 2012). This aim was realized by testing 
two discrete sets of mice with an approximate mean age of 8 and 15-months. The 
younger cohort of mice offered a unique opportunity to study whether there were any 
differential effects of soluble Aβ and plaque-based Aβ on behaviour or neuronal tissue. 
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At the 8-month age point these models express equivalent amounts of soluble Aβ yet 
the AppNL-F mice have little extracellular Aβ plaques whilst the AppNL-G-F mice are 
nearly plaque saturated (Saito et al., 2014). Testing of the older cohort of mice allowed 
us to investigate any behavioural or neuronal change that may have gone undetected 
in the younger mouse cohort. Both models provide the additive benefits of being able 
to isolate the effects of β-amyloidosis in the absence of tauopathy, and to establish 
phenotypes without the artifacts associated with APP overexpression.  
To summarize, the present study was designed in order to better understand the 
neurobiology of social withdrawal and anxiety symptoms in AD by performing a 
targeted characterization of two novel APP knock-in mouse models of the disease. We 
argue that the AppNL-F and AppNL-G-F mice, which typify the initial stages of AD (albeit 
without tauopathy) in a more physiologically relevant way compared with earlier 
transgenic mice, are a practical approach for the in vivo screening of symptoms recently 
linked to preclinical AD in humans. Specifically, we assessed the sociability of the mice 
using the Crawley three-chamber protocol, and anxiety-like behaviours using the open 
field and elevated plus-maze. Ex vivo DTI was then performed to evaluate the 
microstructural integrity of the tissue within the orbitofrontal and anterior cingulate 
cortices, the anterior part of the amygdala, and the dorsal and ventral hippocampus, 
brain regions that are historically associated with social and anxiety-related behaviour. 
Finally, an immunohistochemical analysis investigating the extent of Aβ deposition in 
these regions was carried out on a subset of mice from the 8-month old cohort using 
the monoclonal anti-Aβ 6E10. Aβ deposition was qualitatively assessed and compared 










CHAPTER - 2 
ANXIETY-RELATED & SOCIAL BEHAVIOURS OF THE AppNL-F and AppNL-G-F MICE 
 
A major aim of animal models in science is to elucidate the underlying mechanisms of 
disease, its related behaviours and the neurobiological links between the two, and to 
assess pre-clinically the viability of novel pharmacological treatments. To this end, AD 
model mice have traditionally been used to gain insight on the relationship between 
AD mediated pathology and cognitive symptoms, such as memory loss and executive 
dysfunction. Cognitive symptoms are indeed a key behavioural feature of AD, yet 
symptoms such as anxiety and social withdrawal are equally as common and 
debilitating for the AD patient as well as being a main source of caregiver distress. 
Moreover, the late-life onset of impactful and sustained psychiatric illness as a 
potential harbinger of AD is increasingly being recognized, and it is well evidenced 
that the presence of anxiety and social withdrawal in MCI is associated with a faster 
progression to dementia. Thus, understanding the neurobiological basis of anxiety and 
social withdrawal in the context of the AD brain is a topical initiative, and one that 
requires an appropriate AD model mouse. The AppNL-F and AppNL-G-F mice represent a 
new generation of AD mice based on a knock-in approach that enables the modeling of 
Aβ pathology without the overexpression of APP. Consequently, experimental results 
derived from these mice are less likely to be confounded by the artifacts associated 
with earlier transgenic mice. The behavioural phenotypes of the AppNL-F and AppNL-G-F 
mice are yet to be extensively characterized, and of the handful of published studies 
that are currently available, references to social and anxiety-related behaviours are 
minimal. Thus, the primary aim of this chapter is to extend the behavioural phenotype 
of the AppNL-F and AppNL-G-F mice and investigate for behaviours that are reminiscent of 
the anxiety and social withdrawal symptoms commonly observed in AD. Our main 
intent is to identify whether these mice enable the modeling of the neurobiological 
links between anxiety and social withdrawal and AD, and secondarily, to engage in a 




2.2 Materials and Methods 
All experimental procedures were performed under a UK Home Office Project License 
and Personal Licenses subject to the restrictions and provisions contained in the 
Animals (Scientific Procedures) Act 1986, and approved by Durham University’s 
Animal Welfare Ethical Review Board.  
 
2.2.1 Animals 
2.2.1.1 Subject Mice  
APP knock-in mice (Saito et al., 2014) were sourced from the RIKEN BioResource 
Research Centre (Japan) via Prof. Michel Goedert of Cambridge University’s (UK) MRC 
Laboratory of Molecular Biology. These mice have humanized Aβ sequences with 
familial mutations in the endogenous APP mouse gene. Mice carrying the Swedish 
(KM670/671NL) and Beyreuther/Iberian (I716F) mutations, termed AppNL-F, exhibit an 
increase in total Aβ levels with an elevated ratio of Aβ42 to Aβ40. Mice carrying the 
additional Arctic (E693G) mutation, referred to as AppNL-G-F, exhibit a more 
oligomerization-prone Aβ peptide that results in a threefold faster, more aggressive Aβ 
deposition compared to the AppNL-F mice (Saito et al., 2014). Both models typify the 
pathology seen in preclinical AD without APP overexpression or the interruption of 
other mouse genes. However, these models do not develop tauopathy. Further 
specifications of the model mice are found in Chapter 1.   
 
Upon arrival at Durham University, mice were backcrossed once to the C57BL/6J line 
(Charles River, UK), which is the same background strain as the previous institutions 
where they were bred. We then bred heterozygote pairs (e.g., AppNL-F (+/-) x AppNL-F (+/-)) 
and selected male and female AppNL-F (+/+), AppNL-G-F (+/+) and wild-type(-/-) littermate mice 
for the study. An approximately equal amount of wild-type control mice were selected 
from the AppNL-F and the AppNL-G-F litters. Genotyping was performed by the Principal 
Investigator (PI) and was determined by polymerase chain reaction using an ear biopsy 
method. The genotyping protocols are reported in Saito et al. (2014).  
 
Behavioural tests were conducted on two discrete sets of experimentally naïve mice.             
Set 1 (n=58) had a Mage of 7.9 months (±.08). Set 2 (n=60) had a Mage of 15.4 months (±.04). 
Age groups were balanced by genotype and in turn balanced by sex; Table 2.1.  
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Table 2.1 Descriptive statistics per age group with age reported as number of days postnatal (±SEM).   
 ~ 8 months ~ 15 months 
 Male Female Male Female 
 No. Age No. Age No. Age No. Age 
AppNL-F 10 238 (±4.41) 9 246 (±1.23) 10 465 (±5.37) 10 468 (±3.15) 
AppNL-G-F 10 241 (±5.25) 9 234 (±11.96) 10 464 (±1.38) 10 464 (±2.69) 
Wild-Type 9 249 (±3.76) 11 246 (±1.23) 10 468 (±0.77) 10 475 (±3.32) 
 
 
2.2.1.2 Husbandry  
Mice were weaned at postnatal day 21 and group housed (3-5 mice/cage) with same-
sex littermates in individually ventilated cages (W17.5 x L31 x H14.5 cm). Cage 
bedding included shavings, hay and paper wool, and each cage had cardboard tubes 
and either toy domes or hammocks. Mice were maintained in a temperature (18-22° 
Celsius) and humidity (45-65%) controlled room under a 12:12 light/dark cycle (lights 
on at 08:00). Water and autoclaved pellet food (Special Diets Services, UK; PN RM1AP) 
were available ad libitum. Mice were handled by animal technicians at minimum every 
fortnight for basic husbandry needs.  
 
2.2.2 Apparatus & Procedures 
2.2.2.1 General Procedures 
The author observed in part the PI’s testing of the 8-month old cohort of mice then 
independently tested the 15-month old cohort using the same procedures. Testing was 
carried out during light cycle hours in a dedicated laboratory (W2.26 x L3.43 x H2.39 
m) that was illuminated by standard fluorescent ceiling lights. The mice were 
acclimatized by transferring the home cages to the laboratory for a minimum of thirty 
minutes prior to testing. Handling tubes were then used to transport mice between 
their home cages and the test apparatus. A tripod-supported webcam (Logitech 720p) 
was positioned 70 cm above the apparatus and ANY-mazeTM video tracking software 
(Stoelting Co., Wood Dale, IL, USA) was used to capture and record an animal’s 
movement and location parameters; recordings were initiated immediately after 
placing an animal in an apparatus and continued for the duration of the trial. 
Apparatus were cleaned between subjects with 70% v/v isopropyl alcohol 
(AZOWIPETM; PN 81103) and were left to air dry for 5 minutes.  
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The experimenter was present in the laboratory during testing and out of view, except 
during the elevated plus maze and buried food test when behaviour was live scored. 
All mice completed the test battery in the following order with at least one days rest 
between tests: (1) the open field, (2) the elevated plus-maze, (3) social approach and 
preference for social novelty, (4) social olfaction, and if applicable (5) the buried food 
test.  
 
2.2.2.2 Open Field  
The apparatus (see Figure 2.1) was an empty, open-top box (45 cm3) constructed 
entirely of white opaque acrylic. The internal arena floor (44 cm2) was partitioned into 
three virtual zones using the ANY-mazeTM software. The center zone was set at 17.5 
cm2. The area within 8 cm of the wall was considered the outer zone, and the 
intermediate zone was the remaining area between the center and outer zones. Mice 
were released along the back wall of the arena and were allowed to move freely and 
undisturbed for 30 minutes. ANY-mazeTM auto-capture feature recorded the total 
distance moved in addition to the number of entries into, and the time spent in, each of 
the three zones. An entry into a zone was counted when an animal’s centre point 












                         Figure 2.1. Schematic illustration of the Open Field apparatus. The open field paradigm    
                         is a common measure of exploratory behaviour and general activity in rodents. A mouse  
                         freely explores an empty apparatus and anxiety-like levels are principally inferred by the      
                         time spent in the centre zone. Less time in the centre zone relative to the wild-type control 
                         mice is traditionally regarded as an indication of an anxiogenic-like open field profile.  
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2.2.2.3 Elevated Plus-Maze 
The maze (see Figure 2.2) was constructed entirely of white opaque acrylic and was 
elevated 38 cm from the floor on a transparent acrylic stand. There were four equally 
spaced arms (L33 x W5 cm each) extending from a central square resembling the shape 
of a plus sign. There were two opposing open arms (with no ledges), and two opposing 
walled arms. The junction of the four arms was 5 cm2. 
Mice were released in the centre of the maze facing away from the experimenter 
toward an open arm; the same arm in all instances. The mice were allowed to move 
freely and undisturbed for 5 minutes. ANY-mazeTM recorded the number of entries 
onto, and the time spent on, the open arms, closed arms and the centre square. An 
entry was counted when all four paws crossed the entrance line of an arm or the centre 
square. In addition to the conventional spatiotemporal parameters captured by ANY-
mazeTM, the experimenter sat silently 2.5 m from the maze and recorded the number of 
head-dips by pressing a keyboard button each time a mouse looked over the edge of an 
open arm towards the floor; ANY-mazeTM then tallied the number of key presses. The 
‘protected’ head-dips that occurred from the centre square were not differentiated from 













                   Figure 2.2. Schematic illustration of the Elevated Plus-Maze. The plus-maze is the 
                   most common test of rodent anxiety-like behaviour. Open arm activity is the main  
                   determinant that correlates with anxiety. Fewer entries onto the open arms and less     
                   time on the open arms relative to wild-type mice indicates high anxiety-like levels.   
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The choice of parameter measures used to assess behaviour in the plus-maze was 
guided by the selection criteria in Holmes and Rodgers (1998), Rodgers and Dalvi 
(1997) and Fernandes and File (1996). The primary indices of anxiety are the number of 
entries into the open arms and the time spent on the open arms; fewer entries and less 
time reflect anxiety-like behaviour. To correct for activity-induced artifacts, open arm 
data is expressed as a percentage of the total number of arm entries (open + closed), 
and a percentage of the total time spent in each arm (open + closed). Central square 
activity is not scored as part of either the open or closed arms, based on the factor 
analysis study by Fernandes and File (1996) that indicated it loaded separately from 
arm activity. The total number of closed arm entries best describes general exploratory 
behaviour, and the total number of arm transitions is used to quantify general 
locomotion. These latter two parameters help to interpret open arm activity.  
 
2.2.2.4 Social Approach and Preference for Social Novelty  
The apparatus was an open-top, white opaque acrylic box divided into three equal 
sized chambers (W20 x L40 x H23 cm) by two transparent acrylic walls (W5 x L40 x 
H23 cm). Dividing walls had a centrally placed doorway (W7.2 x H8 cm) with a 
transparent, removable guillotine door used to control access to side chambers.   
 
Social approach and preference for social novelty were measured separately in this 
two-stage test (see Figure 2.3). Testing was immediately preceded by a fifteen-minute 
habituation period during which time the subject mouse freely explored the empty 
apparatus, starting from the centre chamber. Once the habituation period ended the 
doors were replaced and the subject mouse was confined to the centre chamber. An 
inverted wire pencil cup (Spectrum Diversified; SKU 31570) was then placed in the 
middle of each side chamber, 6 cm from the back wall. The wire cups (DIA10.2 x H10.8 
cm) were made up of vertical stainless steel bars that were spaced 9 mm apart, and 
were weighted with a water-filled, 250 mL glass laboratory bottle (DURAN®; PN 
21.801.36.5). An adult wild-type mouse that was sex-matched and wholly unfamiliar to 
the subject mouse was placed underneath one of the wire cups; left and right 
placement was counterbalanced across groups. To test social approach, the subject 
mouse was given access to the side chambers and was allowed to freely explore for 10 
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minutes. When the social approach test ended, the doors were replaced and the subject 
mouse was confined to the centre chamber. To test preference for social novelty, a 
second stranger mouse (S2) with the same characteristics as stranger mouse 1 (S1) was 
placed underneath the remaining wire cup. The subject mouse was again given access 
to the side chambers and allowed to freely explore for 10 minutes. At each stage of 
testing the guillotine doors were removed simultaneously to avoid influencing an 
animal’s movement. The same four male and four female stimulus mice were used 
throughout the study, and their identity was counterbalanced across groups; mouse A 
= S1 and mouse B = S2, then mouse B = S1 and mouse A = S2, etc.    
 
 
The main parameter was the time spent exploring in proximity to the wire cups. The 
author collected this data retrospectively by manually scoring session recordings. 
Videos were replayed offline using ANY-MazeTM software. A virtual zone was overlaid 
on to the recorded images to create a gap of 2 cm between the base of the wire cups and 
the perimeter boundary of the circular zone. When a subject mouse’s nose fell on or 
within one of these virtual zones a keyboard button was pressed, then released when 
the animal’s nose exited the zone (separate keys were assigned for left and right). 
Exploration was not scored if an animal used a cup to rear upward with its nose facing 
A B 
Figure 2.3. Schematic illustration of the Crawley three-chamber test. A) Social Approach. The subject 
mouse has a choice whether to explore the unfamiliar, sex-matched mouse or the empty cage. Preferential 
exploration of the stranger mouse indicates social approach behaviour. B) Preference for Social Novelty. 
The subject mouse has the choice whether to explore a newly introduced stranger mouse or the original 
stranger mouse. Preferential exploration of the novel stranger mouse shows a preference for social novelty.  
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toward the ceiling, or if an animal’s nose fell briefly within a zone for the purpose of 
moving to another area of the arena. The author scored the entire dataset blind to 
genotype and sex. The author then re-scored 40% of trials from each age group to 
assess intra-scorer reliability and found a significant correlation between scores: r = 
0.89, p = .004 (8-months); r = .091, p < .001 (15-months).  
 
Performance in the (1) social approach and (2) preference for social novelty test was 
calculated as a D2 discrimination ratio (Ennaceur & Delacour, 1988) in order to 
accurately assess the preference for a cue by accounting for the variability in raw 
exploration times. These ‘preference scores’ were calculated as: (1) [(the time spent 
exploring S1 – the empty cup) / (the time spent exploring S1 + the empty cup)], and (2) 
[(the time spent exploring S2 – S1) / (the time spent exploring S2 + S1)].  Scores can vary 
between  +1 and -1. Using the social approach test as an example, a score greater than 
zero indicates more time spent exploring S1 than the empty cup, vice versa for a score 
below zero. A score of zero indicates an equal amount of time spent exploring S1 and 
the empty cup, or no preferential exploration of either S1 or the empty cup.  
 
2.2.2.5 Social Olfaction  
The Crawley sociability and preference for social novelty protocol was adapted to test 
social olfaction (Dachtler et al., 2014). The same three-chamber apparatus and general 
procedure was used for this one-stage test. The subject mouse was confined to the 
centre chamber following the fifteen-minute habituation period. The inverted wire 
pencil cups were placed in the side chambers and an open petri dish (DIA33 x H10 
mm) was positioned centrally underneath each cup. One dish was filled with new 
bedding whereas the other dish was filled with soiled bedding from a cage of mice 
(minimum 3) that were sex-matched to the subject mouse and not used as stimulus 
mice in the social approach and preference for social novelty tests. The subject mouse 
was then given access to the side chambers and was allowed to freely explore for 10 
minutes. The placement of the soiled bedding was left and right counterbalanced 
across groups.  
 
Social olfaction was quantified by applying the same method of manual scoring 
described in the social approach and preference for social novelty tests. The author 
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performed all manual scoring, and was blind to genotype and sex. Intra-scorer 
reliability was significant (40% trials) at 8-months (r = .90, p < .001) and 15-months (r = 
.88, p < .011). Performance was calculated as a discrimination ratio (d2) defined as: 
[(time spent exploring the soiled bedding – time spent exploring the clean bedding) / 
(time spent exploring the soiled bedding + fresh bedding)]. A score greater than zero 
(maximum of 1) indicates more time spent exploring the soiled bedding than the clean 
bedding, vice versa for a score below zero (minimum of  -1). A score of zero indicates a 
null preference, or an equal amount of time exploring both beddings.  
 
2.2.2.6 Buried Food Test  
We evaluated mouse ability to smell volatile odours using Yang and Crawley’s (2009) 
buried food test. The motive was to assess anosmia as a potential confounding factor in 
the tests of social behaviour. Thirty-two of the 39 mice were from the original test 
battery: 4 male AppNL-F (M=476.50 ±8.37 days), 21 AppNL-G-F (M=471.57 ±4.26 days; 11 
male) and 14 wild-type (M=441.14 ±14.64 days; 10 male).  
 
The main parameter here is the latency to uncover food hidden beneath a layer of clean 
cage bedding. Weetos™, a crunchy, chocolate-flavoured wheat cereal, were placed in 
home cages for two consecutive days prior to testing; one piece per mouse, per day, 
broken into quarters and scattered throughout the cage. The cages were checked each 
morning to ensure the cereal was consumed and therefore palatable to the mice. The 
mice were then put on an overnight fast. The chow pellets were removed for 
approximately nineteen hours prior to testing. The test began by acclimatising the 
mouse for five minutes to a standard polycarbonate cage (W17.5 x L31 x H14.5 cm) 
containing clean bedding 3 cm deep. The mouse was then transferred to an empty cage. 
A Weetos™ piece was then placed in a randomly chosen area 1 cm beneath the cage 
bedding. The mouse was then re-introduced to the cage and the cage lid replaced. The 
experimenter retreated approximately 2 m from the cage and recorded with a 
stopwatch the animal’s latency to find the cereal piece (up to a maximum limit of 15 
minutes). A mouse was considered to have uncovered the food once it began to eat. 
Cages were cleaned between subjects with 70% v/v isopropyl alcohol and new bedding 
was used.  
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2.2.3 Data Analysis 
Data was analysed using two-way independent ANOVA with genotype and sex as the 
between-subjects factors. Where data violated the assumption of homoscedasticity 
and/or normality the research team decided collectively to proceed with analysis given 
the general robustness of ANOVA and given that there are no viable non-parametric 
alternatives to two-way ANOVA. Data from the social behaviour assays were analysed 
using a repeated measures two-way ANOVA with time as the within-subjects factor 
(e.g., time spent exploring stranger mouse 1 vs. time spent exploring the empty cup). 
One-sample t-tests were performed on the discrimination ratios (d2) to assess whether 
the mean d2 scores differed from zero. If data was not normally distributed a one-
sample Wilcoxon signed rank test was run. As this yielded similar results in each 
instance, only the parametric test results are reported.  
 
Pair-wise comparisons between genotypes were adjusted using the Bonferroni 
correction, which was chosen in order to mitigate the increased risk of finding a false 
positive due to heteroscedasticity. The less conservative Tukey correction was also 
applied as a matter of interest, and was found to yield similar results in all instances 
(data not included). The variable sex was primarily of interest as an interaction variable 
rather than a main effect. Therefore, main effects of sex are reported, but with limited 
interpretation. Interactions were investigated using simple main effects analysis. For 
simple main effect analysis by one-way ANOVA, where Levene’s test for equality of 
variances indicated significant differences the Welch correction is reported with 
Games-Howell pairwise comparisons. All simple main effects analyses by t-test met the 
assumption of homoscedasticity. Non-parametric equivalents were run if data for the 
simple main effects analyses were not normally distributed. Since results did not differ, 
only the parametric test results are reported.  
 
All statistical analyses were performed by the author, using IBM™ SPSS© v.22.0. The 
critical α level was set to p ≤ 0.05. Graphs were made using Chart.js v.2.8.0, and were 
designed by the author to illustrate the underlying distribution of data. Statistical 
significance within figures is illustrated as: *(p ≤ 0.05), **(p < 0.01) and ***(p < 0.001). All 
data are expressed as mean ± SEM.  
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2.3 Results  
2.3.1 Anxiety-Related Measures  
Human studies have recently shown that anxiety may act as an early indicator of AD 
(e.g., Donovan et al., 2018; Hanseeuw et al., 2018). To investigate this further, and to 
identify if the APP knock-in mice display an analogous phenotype, we evaluated 
anxiety-related behaviours in the AppNL-F and AppNL-G-F mice using two of the most 
relied upon tests of rodent emotionality: the open field and elevated plus-maze.  
 
2.3.1.1 Results at the 8-month age point 
2.3.1.1.1 Open Field  
8-month old AppNL-G-F mice exhibit heightened avoidance of the open field centre zone 
An ANOVA of the mean time spent in the centre zone of the open field by the 8-month 
old mice revealed an effect of genotype, F(2,52) = 7.49, p = 0.001 (Fig. 2.4), no effect of sex 
F(1,52) = 3.53, p = 0.066, and no interaction between genotype and sex, F(2,52) = 0.51,     p = 
0.603. Over the course of the 30-minute open field trial the AppNL-G-F mice spent 
significantly less time exploring the central area of the apparatus compared with the 
wild-type mice (p = 0.003) and the AppNL-F mice (p = 0.006); there was no difference 











          
 
Figure 2.4. Mean (±SEM) time spent in the centre zone of the open field at 8-months. 
                   The AppNL-G-F mice spent significantly less time exploring the central area of the arena. 
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8-month old AppNL-G-F mice are thigmotactic compared to wild-type and AppNL-F mice 
To establish whether the 8-month old APP knock-in mice were more thigmotactic 
compared with the wild-type control mice, an ANOVA was carried out on the mean 
amount of time spent in the outer zone of the open field. Due to the intermediate zone, 
the time spent in the outer zone nearer to the walls of the apparatus is not an inverse 
measure of the time spent in the centre zone. The ANOVA revealed an effect of 
genotype, F(2,52) = 10.34, p < 0.001 (Fig. 2.5), an effect of sex, F(1,52) = 4.73, p = 0.034 (M > F), 
and no interaction between genotype and sex, F(2,52) = 0.76, p = 0.475. Pairwise 
comparisons showed that the AppNL-G-F mice spent significantly more time in the 
periphery areas of the apparatus compared with the wild-type mice (p = 0.001) and the 
AppNL-F mice (p = 0.001); the AppNL-F mice and the wild-type mice did not differ in the 
amount of time spent in the outer zone (p = 1.000). The 8-month old AppNL-G-F mice 
display an ostensibly-anxiogenic profile in the open field. They spend less time in the 
central area of the apparatus, and more time nearer to the walls of the apparatus, 
















               Figure 2.5. Mean (±SEM) time spent in the outer zone of the open field at 8-months. 
              The AppNL-G-F mice exhibited an increased level of thigmotaxis. They spent significantly 
              more time nearer to the walls of the apparatus compared to AppNL-F and wild-type mice. 
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8-month old AppNL-G-F mice enter the centre zone less frequently than wild-type mice 
This ostensibly-anxiogenic open field profile observed in the 8-month old AppNL-G-F 
mice was further investigated by assessing the frequency of centre zone entries, which 
was measured as a ratio of the total number of entries into all three zones. A reduced 
percentage of centre zone entries relative to wild-type control mice are interpreted as 
evidence of heighted anxiety-like behaviour (Prut & Belzung, 2003).	 The ANOVA 
yielded an effect of genotype, F(2,52) = 4.23, p = 0.020 (Fig. 2.6), with no effect of sex F(1,52) = 
0.81, p = 0.370, and no interaction between genotype and sex, F(2,52) = 1.02, p = 0.360. The 
frequency of centre zone entries was significantly reduced in the AppNL-G-F mice 
(M=15.52 ±.30%) compared with the wild-type mice (M=17.62 ±.51%;     p = 0.015). The 
frequency of centre zone entries did not differ between the AppNL-G-F and AppNL-F mice 
(M=16.68 ±.63%; p = 0.362), or the AppNL-F and wild-type mice (p = 0.567). This result 
corroborates our initial finding that the 8-month old AppNL-G-F mice have an ostensibly-

















            Figure 2.6. Mean (±SEM) percentage of entries into the open field centre zone at 8-months. 
            The AppNL-G-F mice displayed a reduced percentage of centre zone entries compared with the 
            wild-type mice which supports a finding of an ostensibly-anxiogenic open field profile. 
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8-month old APP knock-in mice display normal locomotor activity in the open field 
To investigate whether altered locomotor activity was driving the anxiogenic-like open 
field behaviour in the 8-month old AppNL-G-F mice, we analysed the mean distance 
traversed in 5-minute time blocks using repeated measures ANOVA. Over the course 
of the 30-minute trial, the AppNL-G-F mice traversed a similar distance (M=85.02 ±3.9) 
compared with the wild-type mice (M=74.45 ±6.5) and the AppNL-F mice (M=69.88 ±4.3), 
[RM ANOVA: genotype, F(2,52) = 2.09, p = 0.133 (Fig. 2.7); sex, F(1,52) = 1.52, p = 0.224; 
interaction between genotype and sex, F(2,52) = 0.26, p = 0.766)]. The effect of time-block 
was significant, F(5,260) = 19.47, p < 0.001, and also anticipated, given the well-established 
result of habituation activity in the open field test (Bailey, Rustay & Crawley, 2006). 
There was no interaction between time block, genotype and sex, F(2,10) = 0.31, p = 0.978, 
however time-block and genotype interacted, F(10,260) = 16.42, p = 0.018. Using simple 
main effects analysis by one-way ANOVA, we found that the AppNL-G-F mice traversed 
a significantly greater distance compared to the AppNL-F mice (p = 0.042) during the 














                Figure 2.7. Mean (±SEM) distance traversed in the open field at 8-months of age.      
                   APP knock-in mice displayed intact motor function, traversing similar distances 




















As a second and final measure of general locomotion, an ANOVA was conducted on 
the mean number of total zone entries over the course of the 30-minute open field trial. 
There was an effect of sex, F(1,52) = 5.33, p = 0.025 (M > F), no effect of genotype, F(2,52) = 
1.19, p = 0.313 (Fig. 2.8), and no interaction between genotype and sex, F(2,52) = 0.13, p = 
0.879. Taken together, these results indicate that the ambulatory ability of the 8-month 
old APP knock-in mice was unaltered, which in turn suggests that the behavioural 
performance of the 8-month old AppNL-G-F mice, or more specifically, the avoidance of 
the central area of the apparatus and an increased tendency for wall-hugging, was 

















           
 
             Figure 2.8. Mean (±SEM) number of total zone entries in the open field at 8-months. 
              APP knock-in mice displayed unaltered ambulation. They made a similar number of    




2.3.1.1.2 Elevated Plus-Maze  
8-month old AppNL-G-F mice exhibit an increase in open arm activity in the plus-maze  
Open arm activity is the critical determinant of anxiety-like behaviour in the elevated 
plus-maze. Less time spent on the open arms of the maze and fewer open arm entries 
are indications of an anxiogenic-like profile. An ANOVA of the mean percentage of 
time spent by the 8-month old mice in the open arms of the maze yielded an effect of 
genotype, F(2,52) = 5.68, p = 0.006 (Fig. 2.9), no effect of sex, F(1,52) = 3.59, p = 0.064, and no 
interaction between genotype and sex, F(2,52) = 0.02, p = 0.981. Pairwise comparisons 
confirmed that over the course of the 5-minute trial the AppNL-G-F mice spent 
significantly more time (M=18.14 ±3.52%) on the open arms of the maze compared with 
the wild-type mice (M=7.68 ±1.84%; p = 0.016) and the AppNL-F mice (M=7.84 ±2.10%; p = 
0.020); the percentage of time spent on the open arms did not differ between the AppNL-















                       Figure 2.9. Mean (±SEM) percentage of time spent on the open arms at 8-months. 
                       The AppNL-G-F mice show an increase in open arm activity by spending significantly  
                       more time on the open arms of the maze relative to the wild-type and AppNL-F mice.  
 
	 30	
Open arm activity was further analysed by assessing the percentage frequency of open 
arm entries over the 5-minute trial. The ANOVA revealed an effect of genotype, F(2,52) = 
5.58, p = 0.005 (Fig. 2.10), and an effect of sex, F(1,52) = 13.12, p = 0.001 (M < F), with no 
interaction between genotype and sex, F(2,52) = 0.81, p = 0.450. Pairwise comparisons 
confirmed that the AppNL-G-F mice had a significantly higher frequency of open arm 
entries (M=32.04 ±3.29%) compared with the wild-type mice (M=18.87 ±2.84%, p = 0.013) 
and the AppNL-F mice (M=19.40 ±4.16%, p = 0.020); there was no difference between the 
AppNL-F mice and wild-type mice (p = 1.000) in the percentage of open arm entries. 
Together these results indicate a marked increase in open arm activity in the 8-month 
old AppNL-G-F mice, which is evidence of an ostensibly-anxiolytic plus-maze profile. An 
intriguingly contradictory behavioural pattern has emerged whereby the 8-month old 
AppNL-G-F mice exhibit an ostensibly-anxiogenic profile in the open field yet an 














                        
                                
 
                                Figure 2.10. Mean (±SEM) percentage of open arm entries at 8-months.  
                                The AppNL-G-F mice display a significantly greater percentage of open arm  
                                entries compared with the wild-type mice and the AppNL-F mice.  
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8-month old APP knock-in mice show typical exploratory activity in the plus-maze  
The extensive open arm activity observed in the 8-month old AppNL-G-F mice may reflect 
low levels of exploratory activity as opposed to anxiolytic-like behaviour. For instance, 
the first arm a mouse transitions into, whether it be closed or open, could be where the 
mouse remains (Bailey & Crawley, 2009). To address this potential confound we 
assessed the number of closed arm entries and the number of total arm transitions. An 
analysis of variance of the mean number of closed arm entries yielded an effect of sex, 
F(1, 52) = 11.79, p = 0.001 (M > F), no effect of genotype, F(2,52) = 0.65, p = 0.524 (Fig. 2.11-A), 
and no interaction between genotype and sex, F(2,52) = 2.28,              p = 0.112. An analysis 
of variance of the mean number of arm transitions revealed no effect of genotype, F(2,52) 
= 0.48, p = 0.623 (Fig. 2.11-B), or sex, F(1,52) = 0.73, p = 0.397, and no interaction between 
genotype and sex, F(2,52) = 0.72, p = 0.492. Together these results indicate that the 
increased open arm activity observed in the 8-month old AppNL-G-F mice is not based on 
















                    Figure 2.11. General exploratory and locomotor activity in the plus-maze at 8-months.     





8-month old APP knock-in mice show equivalent head-dips to wild-type mice 
As a final measure of plus-maze behaviour we assessed the number of head-dips mice 
made during the 5-minute trial. The ANOVA revealed an effect of genotype, F(2,52) = 
3.39, p = 0.041 (Fig. 2.12), no effect of sex, F(1,52) = 2.43, p = 0.125, and no interaction 
between genotype and sex, F(2,52) = 0.19, p = 0.826. Despite the effect of genotype, the 
pairwise comparisons between genotypes did not reach statistical significance. 
However, the AppNL-G-F mice made more head-dips (M=26.13 ±2.77) compared with the 













                        
                          Figure 2.12. Mean (±SEM) number of head-dips in the plus-maze at 8-months.  
 
A brief summary of the results indicates that at the 8-month age-point, there were no 
interactions between genotype and sex on any of the open field or elevated plus-maze 
variables assessed, and the 8-month old AppNL-F mice behaved statistically similar to 
the age-matched wild-type control mice across all anxiety-related measures. Contrarily, 
the 8-month old AppNL-G-F mice did display altered behaviour compared with the wild-
type mice, and the AppNL-F mice. The AppNL-G-F mice displayed an ostensibly-anxiogenic 
profile in the open field yet an ostensibly-anxiolytic profile in the elevated plus maze. 
We now turn to the analyses of anxiety-related behaviour in the 15-month old cohort of 
mice.  
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2.3.1.2 Results at the 15-month age point 
2.3.1.2.1 Open Field 
15-month old APP knock-in mice show unaltered anxiety-like levels in the open field 
An ANOVA conducted on the mean amount of time spent in the centre zone of the 
open field yielded no effect of genotype, F(2,54) = 0.06, p = 0.941 (Fig. 2.13), no effect of 
sex, F(1,54) = 3.29, p = 0.075, and no interaction between genotype and sex, F(2,54) = 0.29,  p = 
0.744. Furthermore, an ANOVA conducted on the mean amount of time spent in the 
outer zone of the open field yielded no effect of genotype, F(2,54) = 2.47, p = 0.094 (Fig. 
2.14), an effect of sex, F(1,54) = 4.14, p = 0.047 (M < F), and no interaction between 
genotype and sex, F(2,54) = 0.38, p = 0.688. As a third and final measure of anxiety-related 
behaviour in the open field we assessed the percentage of centre zone entries. There 
was no difference between genotypes, F(2,54) = 0.22, p = 0.801 (Fig. 2.15), no difference 
between males and females, F(1,54) = 0.85, p = 0.362, and no interaction between genotype 
and sex, F(2,54) = 0.09, p = 0.912. These results demonstrate that the 15-month old AppNL-F 
and AppNL-G-F knock-in mice did not exhibit anxiety-like behaviours when moving 















                 Figure 2.13. Mean (±SEM) time spent in the centre zone of the open field at 15-months.       










          
               
         
 
 
               
              Figure 2.14. Mean (±SEM) time spent in the outer zone of the open field at 15-months.     
















                 Figure 2.15. Mean (±SEM) percentage of entries into the center zone at 15-months.  
                 There were no differences between genotypes in the percentage of centre zone entries. 
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15-month old AppNL-G-F mice exhibit some evidence of hyperactivity in the open field 
Measures of general ambulation in the open field remain informative regardless of null 
anxiety-related findings, and serve as standard protocol when establishing the 
phenotype of novel mouse models. To assess locomotor activity in the 15-month old 
APP knock-in mice, a repeated measures ANOVA was run on the mean distances 
traversed over the course of the 30-minute open field trial. There was a significant 
effect of genotype, F(2,54) = 12.74, p < 0.001 (Fig. 2.16). Pairwise comparisons confirmed 
that the AppNL-G-F mice traversed a significantly greater distance in total (M=106.68 
±5.42) compared with the wild-type mice (M=74.46 ±4.75; p < 0.001) and the AppNL-F 
mice (M=86.82 ±4.75; p = 0.010). There was no effect of sex, F(1,54) = 0.38, p = 0.539, and no 
interaction between genotype and sex, F(2,54) = 2.83, p = 0.067, on the overall distance 
traversed. There was a significant effect of time block, F(5,270) = 24.14 = p < 0.001, which 
does not warrant a simple-main effects analysis as previously implied. There were no 
interactions to indicate any differences between groups in the pattern of change across 
time-blocks: [RM ANOVA: time-block x genotype x sex, F(2,10) = 1.06, p = 0.344; time-




                   Figure 2.16. Mean (±SEM) distances traversed in the open field at 15 months.   
                   AppNL-G-F mice traversed a significantly greater distance overall compared with  
                   the wild-type mice and the AppNL-F mice. There were no interactions to indicate  



















As a second and final measure of locomotor activity in the open field, an ANOVA was 
conducted on the total number of zone entries made over the course of the 30-minute 
trial. There was no effect of genotype, F(2,54) = 2.13, p = 0.129 (Fig. 2.17), and no effect of 
sex, F(1,54) = 0.96, p = 0.331. There was an interaction between genotype and sex, F(2,52) = 
3.35, p = 0.042. Simple main effects analysis by t-tests yielded a marginally significant 
difference between male and female wild-type mice, t(18) = 2.06, p = 0.054, with no 
difference between male and female AppNL-F mice, t(18) = -1.44, p = 0.167, or male and 
female AppNL-G-F mice, t(18) = 1.17, p = 0.255. Simple main effects analysis by one-way 
ANOVA for each sex was also included for completeness. There was no difference 
among the male mice in the overall number of zone entries, F(2, 29) = 2.38,    p = 0.112. 
Although the one-way ANOVA among female mice was significant, F(2,29) = 3.45, p = 
0.046, the pairwise comparisons did not reach statistical significance; wild-type to 
AppNL-F (p = 0.076), wild-type to AppNL-G-F (p = 0.116) and AppNL-F to AppNL-G-F (p = 1.000). 
Together these results demonstrate that the 15-month old AppNL-G-F mice are mildly 
hyperactive in the open field. They traversed a greater total distance compared with 
the wild-type mice and the AppNL-F mice, yet they did not display any difference in the 















                     Figure 2.17. Mean (±SEM) number of total zone entries in the open field at 15 months.   
                     There was no difference between genotypes in the overall number of zone entries. There 
                     was a marginally significant difference between male and female wild-type mice.  
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2.3.1.2.2 Elevated Plus-Maze 
15-month old AppNL-G-F mice show an increase in open arm activity in the plus- maze  
The primary index of anxiety-like behaviour on the plus-maze is open arm activity, 
which, as previously mentioned, is inferred by the percentage of time spent on the 
open arms and the percentage of open arm entries, with each variable being a function 
of the overall arm activity (open + closed). An analysis of variance of the average 
percentage of time spent on the open arms by the 15-month old mice revealed an effect 
of genotype, F(2,54) = 19.19, p < 0.001 (Fig. 2.18-A), no effect of sex, F(1,54) = 0.002, p = 0.966, 
and no interaction between genotype and sex, F(2,54) = 0.34, p = 0.712. Pairwise 
comparisons confirmed that the AppNL-G-F mice spent a significantly greater percentage 
of time (M=39.17 ±4.90%) on the open arms compared with the wild-type mice (M=9.30 
1.77%; p < 0.001) and the AppNL-F mice (M=16.35 ±3.06%; p < 0.001); there was no 
difference in the percentage of open arm time between the AppNL-F mice and the wild-
type mice (p = 0.503). An analysis of variance of the mean percentage frequency of open 
arm entries yielded an effect of genotype, F(2,54) = 13.01, p < 0.001 (Fig. 2.18-B), no effect 
of sex, F(1,54) = 1.37, p = 0.247, and no interaction between genotype and sex, F(2,54) = 0.32, 
p = 0.730. Pairwise comparisons showed that the AppNL-G-F mice made a significantly 
greater percentage of open arm entries (M=45.56 ±4.21%) compared with the wild-type 
mice (M=20.86 ±2.70%, p < 0.001) and the AppNL-F mice (M=27.36 ±3.47%, p = 0.002); there 
was no difference in the percentage of open arm entries between the AppNL-F mice and 
the wild-type mice (p = 0.603). Together these results indicate that the 15-month old 
AppNL-G-F mice, but not the 15-month old AppNL-F mice, have an ostensibly-anxiolytic 
plus-maze profile, when allowed to move freely and undisturbed over the course of a 
5-minute trial. This finding replicates the ostensibly-anxiolytic plus-maze profile 






































 Figure 2.18. Open arm activity in the elevated plus-maze at 15-months. 
                               AppNL-G-F mice exhibited an increase in open arm activity compared with 
                               the wild-type mice and the AppNL-F mice, which indicates and ostensibly- 
                               anxiolytic plus-maze profile. (A) Mean (±SEM) percentage of time on the  





15-month old APP knock-in mice have normal exploratory activity in the plus-maze  
Increased open arm activity may reflect low levels of exploratory activity or altered 
ambulation. To assess exploratory activity an ANOVA was conducted on the average 
number of entries made into the closed arms over the 5-minute trial. There was a 
marginally significant effect of genotype, F(2,54) = 2.99, p = 0.058 (Fig. 2.19-A), with no 
effect of sex, F(1,54) = 1.56, p = 0.217, and no interaction between genotype and sex, F(2,54) = 
0.22, p = 0.801. On average the AppNL-G-F mice made 11.4 (±.94) closed arm entries 
compared to the wild-type mice (M=14.6 ±.87; p = 0.071) and the AppNL-F mice (M=13.9 
±1.05; p = 0.223). Locomotor activity was assessed by an ANOVA of the mean number 
of overall arm transitions. We found no effect of genotype, F(2,54) = 1.62, p = 0.208 (Fig. 
2.19-B), no effect of sex, F(1,54) = 0.61, p = 0.440, and no interaction between genotype and 
sex, F(2,54) = 1.02, p = 0.366. The rate of arm transitions was only slightly higher in the 
AppNL-G-F mice (M=23.30 ±2.45) compared with the wild-type mice (M=18.65 ±1.11) and 
AppNL-F mice (M=18.65 ±1.11). Together these results show that the ostensibly-anxiolytic 
plus-maze profile of the 15-month old AppNL-G-F mice is not based on a change in 













                        
                      Figure 2.19. General exploratory and locomotor activity in the plus-maze at 15-months.     
                      (A) Mean (±SEM) entries into closed arms. (B) Mean (±SEM) number of arm transitions. 
A B 
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15-month old AppNL-G-F mice make significantly more head-dips in the plus-maze 
There was an effect of genotype, F(2,54) = 11.66, p < 0.001 (Fig. 2.20), no effect of sex, F(1,54) 
= 1.19, p = 0.280, and no interaction between genotype and sex, F(2,54) = 0.44, p = 0.645, on 
the number of head-dips mice made during the plus-maze trial. Pairwise comparisons 
confirmed that the AppNL-G-F mice made a significantly greater number of head-dips 
(M=32.65 ±3.92) compared with the wild-type mice (M=12.60 ±1.84; p < 0.001) and the 
AppNL-F mice (M=19.20 ±2.75; p = 0.007); there was no difference in the number of head-
dips between the wild-type mice and the AppNL-F mice (p = 0.374). In general, more 
head-dipping is linked with anxiolytic-like behaviour, yet caution is required given 
that we did not distinguish ‘protected’ and ‘unprotected’ head-dips. ‘Protected’ head-
dips, which occur from a closed arm or the central square, may represent risk 
















                 Figure 2.20. Mean (±SEM) number of head-dips in the plus-maze at 15 months. 
 
At 15-months both the AppNL-F and AppNL-G-F mice exhibit unaltered anxiety-like levels 
in the open field; AppNL-G-F showed a mild degree of open-field hyperactivity. The 
ostensibly anxiolytic plus-maze profile in the 15-month old AppNL-G-F mice replicates the 
results observed at 8-months; this was not driven by low exploratory behaviour or 
reduced locomotion. We now turn to the analyses of social behaviour.  
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2.3.2 Measures of Social Behaviour 
Taking into account the reports of social withdrawal as an early symptom of AD (e.g., 
Cuthbert et al., 2019; Jost & Grossberg, 1996), we assessed the willingness of AppNL-F 
and AppNL-G-F mice to approach novel conspecifics using the Crawley three-chamber 
protocol (Moy et al., 2004). To test sociability, mice were given the choice of whether to 
spend time exploring a cage (i.e., the inverted wire cup) containing an unfamiliar 
stimulus mouse or an identical empty cage. To test preference for social novelty, mice 
were given the choice of whether to explore a novel stranger mouse placed underneath 
the previously empty cage or the original stranger mouse. The protocol was then 
adapted to assess whether the APP knock-in mice preferred to approach a social odour 
cue (soiled bedding from a cage of unfamiliar, sex-matched mice) versus a non-social 
odour cue (clean bedding). This social olfaction test is an extension of the original assay 
of sociability, but controls for the potential confounding factor of anxiety caused by the 
presence of a novel conspecific. To briefly review, exploration was defined as the 
subject mouse directing the nose at a distance of ≤ 2 cm to a cage and/or touching a 
cage with the nose, and the discrimination ratios were calculated as [(A-B)/(A+B)] to 
compensate for the variability in individual exploration times.  
 
2.3.2.1 Social Approach & Preference for Social Novelty  
2.3.2.1.1 Results at the 8-month age point  
8-month old APP knock-in mice prefer exploring a stranger mouse to an empty cage 
A repeated-measures ANOVA of mean time spent exploring in proximity to the cages 
showed no effect of genotype, F(2,52) = 1.71, p = 0.190 (Fig. 2.21-A), no effect of sex, F(2,52) = 
1.95, p = 0.168, and no interaction between genotype and sex, F(2,52) = 1.97,  p = 0.149. This 
indicates that there was no difference between groups in their overall tendency to 
explore the stimuli. There was an effect of cage, F(1,52) = 145.21, p < 0.001. Significantly 
more time was spent exploring the cage with the unfamiliar stimulus mouse as 
opposed to the empty cage (overall MD = 80.19 ±6.59), and this pattern was similar 
across groups. There were no interactions between cage and genotype, F(2,52) = 0.55, p = 
0.576, cage and sex, F(1,52) = 0.15, p = 0.697, or cage, genotype and sex, F(2,52) = 1.01, p = 
0.371. To analyse further, an ANOVA of the mean discrimination ratios revealed no 
effect of genotype, F(2,52) = 1.33, p = 0.273 (Fig. 2.21-B), no effect of sex, F(1,52) = 0.82, p = 
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0.368, and no interaction between genotype and sex, F(2,52) = 0.79, p = 0.482. Thus, the 
groups did not differ in their degree of preferential exploration of the stranger mouse 
over the empty cage. Finally, a series of one-sample t-tests revealed that each of the 
mean discrimination scores was significantly above zero: wild-type mice (p < 0.001), 
AppNL-F mice (p = 0.001) and AppNL-G-F mice (p < 0.001). Together these results 



















Figure 2.21. Social approach behaviour in the Crawley 3-chamber test at 8-months.                               
(A) Mean (±SEM) exploration time of each cage. (B) Mean (±SEM) discrimination ratios. 
A 
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8-month old APP knock-in mice are mildly impaired in preference for social novelty 
Preference for social novelty was assessed by repeated-measures ANOVA of the mean 
times spent exploring the cages containing the stimulus mice (Fig. 2.22-A). Genotype 
and sex interacted on the overall time spent exploring in proximity to the cages, F(2,52) = 
3.39,  p = 0.041. Simple main effects analysis by t-test revealed differences between the 
male and female wild-type mice, t(18) = 2.46, p = 0.024 (MD = 47.95 ±19.49), and the male 
and female AppNL-G-F mice, t(17) = 2.41, p = 0.028 (MD = 49.56 ±20.59). In each instance, the 
female mice spent significantly less time exploring the stimuli compared to the male 
mice. Nevertheless, there was an effect of cage, F(1,52) = 12.21, p = 0.001. Significantly 
more time was spent exploring the novel stranger mouse as opposed to the original 
stranger mouse (overall MD = 19.26 ±5.41), and this effect of cage was similar across 
groups. There were no interactions between cage and genotype, F(2,52) = 1.17, p = 0.320, 
cage and sex, F(1,52) = 2.37, p = 0.130, or cage, genotype and sex, F(2,25) = 0.11, p = 0.893.  
 
This observed preferential exploration of the novel stranger mouse was further 
investigated for group differences as a discrimination ratio. The ANOVA yielded no 
effect of genotype, F(2,52) = 2.12 p = 0.130 (Fig. 2.22-B), no effect of sex F(1,52) = 1.76, p 
=0.191, and no interaction between genotype and sex, F(2,52) = .440, p = 0.647. Each group 
preferentially explored the novel stranger mouse over the original stranger mouse, 
with mean discrimination ratios that were statistically similar across groups. However, 
the wild-type mice were the only group to have a discrimination score that differed to 
zero (p = 0.001). The discrimination score did not reach statistical significance in either 
the AppNL-F mice (p = 0.068) or the AppNL-G-F mice (p = 0.425). Taken together, these 
results indicate that the 8-month old APP knock-in mice have a mild impairment in 
preference for social novelty. Although the APP knock-in mice preferentially explored 
the novel stranger mouse over the original stranger mouse, with a discrimination ratio 
that was statistically similar to the wild-type mice, their mean discrimination ratios did 

























      Figure 2.22. Preference for social novelty in the Crawley 3-chamber test at 8 months.  
                   (A) Mean (±SEM) exploration time of stranger mouse 1 and the novel stranger mouse 2. 
                   (B) Mean (±SEM) preference ratios. The preference ratios did not differ between groups. 
                   However, the wild-type mice were the only group to display a ratio significantly above 






2.3.2.1.2 Results at the 15-month age point  
15-month old APP knock-in mice prefer exploring a stranger mouse to an empty cage 
The sociability of the 15-month old mice was assessed using a repeated measures 
ANOVA of the mean times spent exploring the stranger mouse and the empty cage 
(Fig. 2.23-A). There was an effect of sex, F(1,54) = 6.22, p = 0.016 (M > F), with no effect of 
genotype, F(2,54) = 1.37, p = 0.264, and no interaction between genotype and sex, F(2,54) = 
1.095 , p = 0.342). On average, the male mice spent more time exploring in proximity to 
the stimuli compared with the female mice, however, as noted, there were no 
differences between the genotypes in their overall exploration time. There was an effect 
of cage, F(1,54) = 200.34, p < 0.001. Significantly more time was spent exploring the 
stranger mouse as opposed to the empty cage (overall MD = 79.92 ±5.55). This effect of 
cage was similar across groups. There was no interaction between cage and genotype, 
F(2,54) = 0.27, p = 0.767, or cage and sex, F(1,54) = 1.08, p = 0.303, and no interaction between 
cage, genotype and sex, F(2,54) = 0.76, p = 0.473.  
 
To further evaluate whether this preferential exploration of the stranger mouse was 
similar between groups, an analysis of variance of the mean discrimination ratios was 
carried out. There was no effect of genotype, F(2,54) = 1.20, p = 0.310 (Fig. 2.23-B), no effect 
of sex, F(1,54) = 0.01, p = 0.928, and no interaction between genotype and sex, F(2,54) = .214, 
p = 0.808. Thus, the mean discrimination ratios were similar across groups. 
Furthermore, a series of one-sample t-tests confirmed that the mean discrimination 
score for each of the three genotypes was significantly greater than the null 
discrimination score of zero: wild-type mice (p < 0.001), AppNL-F mice (p < 0.001) and 
AppNL-G-F mice (p < 0.001). Taken together, these results demonstrate robust sociability 
in the 15-month old APP knock-in mice. Similar to the 8-month old APP knock-in mice, 
the 15-month old APP knock-in mice preferred to approach a novel conspecific to an 
innate object. Furthermore, the mean discrimination ratios were statistically similar to 
the discrimination ratio displayed by the wild-type mice, and each was significantly 





























              Figure 2.23. Social approach behaviour in the Crawley 3-chamber test at 15-months. 
                  (A) Mean (±SEM) exploration times of the stranger mouse and the identical empty cage. 
                          (B) Mean (±SEM) preference ratios. Each group demonstrated a robust preference for the  





15-month old APP knock-in mice prefer exploring a novel mouse to a familiar mouse 
To assess whether the 15-month old mice displayed a preference for social novelty, a 
repeated measures ANOVA was carried out on the mean times spent exploring in 
proximity to the cages containing the novel stranger mouse and the original stranger 
mouse (Fig. 2.24-A). There was an effect of sex, F(1,54) = 4.86, p = 0.032 (M > F), no effect 
of genotype, F(2,54) = 1.67, p = 0.197, and no interaction between genotype and sex, F(2,54) = 
2.09, p = 0.133. Similar to the sociability test, the male mice spent significantly more 
time exploring in proximity to the stimuli compared with the female mice, with no 
difference between genotypes in overall exploration time. There was an effect of cage, 
F(2,54) = 27.77, p < 0.001. More time was spent exploring the novel stranger mouse as 
opposed to the original stranger mouse (overall MD = 22.44 ±4.33). The effect of cage 
was similar across groups. There was no interaction between cage and genotype, F(2,54) = 
1.26, p = 0.292, cage and sex, F(1,54) = 0.54, p = 0.464, or cage, genotype and sex, F(2,54) = 
2.01, p = 0.144.  
 
This observed preferential exploration of the novel stranger mouse was further 
assessed by an analysis of variances of the mean discrimination ratios. The ANOVA 
yielded no effect of genotype, F(2,54) = 1.51, p = 0.230 (Fig. 2.24-B), no effect of sex, F(1,54) = 
1.16, p = 0.286, and no interaction between genotype and sex, F(2,54) = 1.82, p = 0.171. All 
groups displayed a similar preference for the novel stranger mouse. Furthermore, each 
of the mean discrimination ratios was significantly above the null discrimination score 
of zero: wild-type mice (p = 0.001), AppNL-F mice (p = 0.035) and AppNL-G-F mice (p = 
0.001). Taken together, these results demonstrate that the 15-month old APP knock-in 
mice prefer social novelty. They choose to explore a novel stranger mouse over the 
previously explored unfamiliar mouse, and when quantified as a discrimination ratio, 
there was no difference between the APP knock-in mice and the wild-type mice. The 






























         Figure 2.24. Preference for social novelty in the Crawley 3-chamber test at 15-months. 
          (A) Mean (±SEM) exploration time of stranger mouse 1 and the novel, stranger mouse 2. 
                      (B) Mean (±SEM) preference ratios. The preference ratios were similar between groups,  






2.3.2.3 Social Olfaction 
2.3.2.3.1 Results at the 8-month age point  
8-month old female AppNL-G-F mice exhibit a weaker preference for a social odour cue 
Social olfaction was assessed using a repeated-measures ANOVA on the mean times 
spent exploring in proximity to the cage containing the soiled bedding and the cage 
containing the clean bedding (Fig. 2.25-A). With regard to overall exploration time, 
there was no effect of genotype, F(2,52) = 1.02, p = 0.369, no effect of sex, F(1,52) = 0.99, p = 
0.324, and no interaction between genotype and sex, F(2,52) = .774, p = 0.466. All groups 
spent a similar amount of time exploring in proximity to the stimuli. There was an 
effect of bedding, F(1,52) = 111.60, p < .001. More time was spent exploring the soiled 
bedding than the clean bedding (overall MD = 22.44 ±4.33). However, this effect of 
bedding differed between groups, as was indicated by the interaction between 
bedding, genotype and sex, F(2,52) = 4.31, p = 0.019. To investigate this source of 
difference, a discrimination ratio was calculated for all six groups and a Welch one-way 
ANOVA was carried out. The ANOVA revealed significant group differences, F(5,23.12) = 
2.72, p = 0.045 (Fig. 2.25-B). Games-Howell pairwise comparisons confirmed a 
difference in discrimination ratios between the female and male AppNL-G-F mice (p = 
0.047), and the female AppNL-G-F mice and female wild-type mice (p = 0.050). On average, 
the female AppNL-G-F mice explored the soiled bedding more than the clean bedding. 
However, their mean discrimination ratio was significantly reduced compared with the 
discrimination ratio of the male AppNL-G-F mice and the female wild-type mice. 
Furthermore, except for the female AppNL-G-F mice (p = 0.209), all groups had a 
discrimination ratio that was significantly above zero: male wild-type (p = 0.001); 
female wild-type (p < 0.001); male AppNL-F  (p < 0.001); female AppNL-F (p = 0.015); male 
AppNL-G-F (p < 0.001). Together these results indicate that the 8-month old female AppNL-

























         Figure 2.25. Social olfaction at 8-months of age. (A) Mean (±SEM) times spent exploring the  
          bedding stimuli. (B) Mean (±SEM) preference ratios. Female AppNL-G-F mice displayed a mild 
        social olfaction deficit. They exhibited preferential exploration of the soiled bedding, however, 
          the preference ratio was significantly reduced compared to female wild-type mice, and did  





2.3.2.3.2 Results at the 15-month age point  
15-month old APP knock-in mice exhibit a weaker preference for a social odour cue 
Social olfaction was assessed at the 15-month age point using a repeated measures 
ANOVA of the mean times spent exploring in proximity to the bedding stimuli (Fig. 
2.26-A). In regard to the overall exploration time, there was an effect of sex, F(1,54) = 5.36, 
p = 0.024 (M > F), with no effect of genotype, F(2,54) = 0.87, p = 0.426, and no interaction 
between genotype and sex, F(2,54) = 0.39, p = 0.678. There was an effect of bedding, F(1,54) = 
12.12, p = 0.001. More time was spent exploring in proximity to the soiled bedding than 
the clean bedding (overall MD = 109.84 ±10.91). However, there was an interaction 
between bedding and sex, F(1,54) = 9.09, p = 0.004. The female mice did not preferentially 
explore the soiled bedding (overall MD = -0.002 ±0.05). There was no interaction 
between bedding and genotype, F(2,54) = 0.71, p = 0.499, or bedding, genotype and sex, 
F(2,54) = 0.53, p = 0.591. When comparing the discrimination ratios using a two-way 
ANOVA, there was an effect of sex, F(1,54) = 9.09, p = 0.004 (M > F), with no effect of 
genotype, F(2,54) = 1.57, p = 0.217 (Fig. 2.26-B), and no interaction between genotype and 
sex, F(2,54) = 0.63, p = 0.537. Lastly, the discrimination ratios were tested against the null 
discrimination score of zero using one-sample t-tests. The wild-type mice displayed a 
discrimination ratio that was significantly above zero (p = 0.003) whereas the AppNL-F 
mice (p = 0.074) and the AppNL-G-F mice (p = 0.708) did not. Taken together, these results 
demonstrate that the 15-month old APP knock-in mice are mildly impaired in social 
olfaction. The APP knock-in mice preferentially explored the soiled bedding over the 
clean bedding, and their discrimination ratio was similar to that of the wild-type mice. 
However, neither the AppNL-F mice nor the AppNL-G-F mice displayed a discrimination 
ratio that was significantly different to the null discrimination score of zero. Although 
genotype and sex did not interact when assessing the discrimination ratios, an 
inspection of the corresponding graph (Fig. 2.26-B) indicates that the female APP 

























               Figure 2.26. Social olfaction at 15-months of age. (A) Mean (±SEM) times spent exploring           
               the soiled bedding and the clean bedding. (B) Mean (±SEM) preference ratios. There were 
               no differences between genotypes in their mean preference ratios. However, only the wild- 





2.3.2.4 General Olfactory Ability 
APP knock-in mice exhibit intact olfaction for an odour unrelated to a social cue 
Intact olfaction is critically required to elicit normal social behaviours in mice (Ryan et 
al., 2008). To test the general olfactory ability of mice we measured the latency to find a 
chocolate flavoured cereal piece buried underneath clean cage bedding following an 
approximate nineteen hour period of food deprivation. A Welch one-way ANOVA 
revealed no differences between genotypes in the latency to uncover the food, F(2,7.00) = 
0.541, p = 0.605 (Fig. 2.27-A). Due to the exceptionally small AppNL-F sample size (n=4) 
the analysis was also conducted as an independent t-test between the wild-type mice 
and the AppNL-G-F mice. The latency to uncover the food was again similar between 
groups, t(33) = 0.739, p = 0.465 (Fig. 2.27-B). We can therefore conclude that the mild 
impairment in preference for social novelty displayed by the 8-month old APP knock-
in mice, and the mild social olfaction deficit found in the 8-month old female AppNL-G-F 
mice and the 15-month old APP knock-in mice, was not due to a deficit in general 










                                 Figure 2.27. General olfactory ability as assessed in the buried food test. 
                                 There were no group differences in the latency to uncover a hidden cereal 




2.4 Discussion                                                                                                    
Anxiety and social withdrawal are clinically significant symptoms of AD; they are 
highly prevalent in the disease and are associated with a range of adverse effects.  
Furthermore, late-life emergence of anxiety and social withdrawal is increasingly being 
recognized as a possible harbinger of AD (Ismail et al., 2016; Lyketsos et al., 2011). 
Despite this, the neurobiological basis of these symptoms in the context of the AD brain 
remains unclear. Identifying AD mice that enable the modeling of the neurobiological 
links between anxiety and social withdrawal and AD is thus important. To this end, we 
examined social and anxiety-related behaviours in male and female AppNL-F and AppNL-
G-F mice aged 8 and 15-months.  
 
We assessed social behaviour in the AppNL-F and AppNL-G-F mice using the Crawley 3-
chamber protocol (Moy et al., 2004). It is understood that wild-type mice display a 
propensity for sociability, and also for social novelty whereby a novel conspecific is 
preferentially explored over a previously encountered mouse (Silverman, 2010). In the 
context of the Crawley 3-chamber protocol, an animal is viewed as demonstrating 
sociability and preference for social novelty respectively if under free-choice conditions 
they preferentially explore an unfamiliar sex-matched mouse as opposed to an innate 
object, and then preferentially explore a novel, unfamiliar mouse (sex-matched) over 
the original stranger mouse. It is worthy of note that per the Crawley 3-chamber 
protocol the original stimulus mouse remains in the same location throughout the test, 
and thus, the novel stimulus mouse is introduced in to what may be a less explored 
area of the apparatus. Our results showed that sociability in the 8 and 15-month old 
AppNL-F and AppNL-G-F mice was intact, and there was no difference in sociability 
between the two APP knock-in strains. However, the 8-month old AppNL-F and AppNL-G-
F mice displayed a mild impairment in preference for social novelty that was not 
explained by a general olfaction deficit, whereas preference for social novelty was 
intact at 15 months; preference for social novelty did not differ between the two APP 
knock-in strains. The 8-month old female wild-type and female AppNL-G-F mice spent 
less time overall exploring the stimulus mice during the preference for social novelty 
stage, and the 15-month old female mice spent less time overall exploring the stimulus 
mice in each stage of the test; this indicates a minor sex difference (not based on 
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genotype) in the willingness to engage in social interaction. We describe the behaviour 
in the 8-month old AppNL-F and AppNL-G-F mice as only mildly impaired as they did 
preferentially explore the novel, unfamiliar mouse, and the associated discrimination 
ratios were statistically similar to the wild-type mice. Yet in contrast to the wild-type 
mice, the discrimination ratios were not statistically different to chance, or a null 
preference.  
 
There is currently only one other study that has measured social behaviour in the APP 
knock-in mice. Latif-Hernandez et al. (2017) used the Crawley 3-chamber protocol to 
assess social behaviour in 3, 6 and 10-month old female AppNL-G-F mice, and compared 
the behaviour to the AppNL control mice generated by Saito et al. (2014). The findings in 
Latif-Hernandez et al. (2017) were in line with our study. Sociability was intact in the 
AppNL-G-F mice. Preference for social novelty was intact, but with a mild impairment 
observed at the 10-month age point (i.e., discrimination between the novel stimulus 
mouse and the original stimulus mouse was at chance), which is similar to the mild 
impairment we found in the 8-month old AppNL-G-F mice (and also AppNL-F). As a 
comprehensive study of social behaviours in the APP knock-in mice has not yet been 
performed, more studies are needed in order to confirm the social behaviours of the 
APP knock-in mice. Future investigations would also benefit from including a wider 
array of social interaction tests in order to more precisely describe the social behaviours 
of the APP knock-in mice. These preliminary results suggest that the APP knock-in 
mice do not model the social withdrawal symptoms reminiscent in AD; however, the 
age-dependent change in preference for social novelty observed at 8 and 10-months of 
age in the AppNL-G-F mice may be of interest. 
 
It is also of interest to compare our results to commonly employed AD mice genetically 
modified to overexpress Aβ. Filali, Lalonde and Rivest (2011) tested 6-month old male 
APPswe/PSEN1 mice in the Crawley 3-chamber protocol and found that the animals’ 
willingness to engage in social interaction was intact during each stage of the test; 
however, sociability was at chance and preference for social novelty was significantly 
reduced. Similarly, 6-month old male Thy1-hAPPLond/Swe+ mice displayed intact 
sociability but a significantly reduced preference for social novelty (Faizi et al., 2012). 
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Kosel et al. (2019) tested female 5xFAD mice aged 3, 6, 9 and 12 months and found that 
sociability and preference for social novelty was intact relative to the control mice, yet 
the 5xFAD mice did display an age dependent reduction in the willingness (i.e., 
amount to time) to engage with the stranger mouse during the sociability test. In all 
three studies social interaction was measured as the time spent sniffing the stimulus 
mice. Using a paradigm that permitted contact between subject and control mice, 
Deacon et al. (2009) found no effect of AD-pathology on the sociability of 23 month-old 
female Tg2576 mice, and Bories et al. (2012) found no effect of AD-pathology on the 
sociability of 12 and 18-month old male 3xTg-AD mice or 12-month old female 3xTg-
AD mice. However, 18-month old female 3xTg-AD mice showed a reduction in social 
interaction; this is a time point at which tau pathology has developed in these mice in 
addition to the Aβ. Different methods of measuring social interaction seemingly 
generate different results. Our results were in line with Kosel et al. (2019) suggesting 
that there are similarities between the APP knock-in mice and mice that achieve Aβ by 
APP overexpression, yet the more pronounced preference for social novelty deficit in 
Filali, Lalonde and Rivest (2011) and Faizi et al. (2012) suggests the possibility of a 
behavioural artifact of APP overexpression; however, this statement would require 
further consideration.  
 
We pre-emptively investigated the potential impact of anxiety on social interaction by 
testing the animals’ willingness to approach a social odour cue in the absence of a 
novel conspecific. The Crawley 3-chamber protocol was modified by replacing the 
novel conspecific with soiled bedding from a cage of sex-matched unfamiliar mice. We 
measured whether an animal preferentially explored soiled bedding over clean 
bedding. The 8-month old female AppNL-G-F mice displayed a social olfaction deficit 
relative to the male AppNL-G-F mice and the female wild-type mice; however, they spent 
a similar amount of time overall exploring the stimuli. The 15-month old AppNL-F and 
AppNL-G-F mice displayed a mild social olfaction deficit. Their preferential exploration of 
the soiled bedding was at chance, and this was likely due to the fact that the female 
mice (including wild-type mice) showed a reduced motivation to explore either of the 
stimuli, and the female mice (including the wild-type mice) did not display a 
preference for the soiled bedding. The buried food test showed that these deficits were 
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unlikely to have been caused by anosmia given that the 15-month old AppNL-F and 
AppNL-G-F mice found a cereal piece hidden underneath clean cage bedding as easily as 
the wild-type control mice; however, the author notes a lack of data for female AppNL-F 
mice and a sample size that precluded us from investigating an interaction between 
genotype and sex (visual inspection of the accompanying graph indicated that female 
mice were not impaired in the buried food test). Similarly, Kosel et al. (2019) found that 
female 5xFAD mice overexpressing APP displayed an age-related decrease in sniffing 
durations in response to social odours from 3 to 12 months of age. Our results indicate 
that a reduced motivation of female AD mice to explore a social odour is not an artifact 
of the APP overexpression paradigm; however, additional studies would need to be 
reviewed in order to corroborate this finding. It is unclear why we would observe 
changes in motivation to explore a social odour cue, but not a novel conspecific. The 
author notes that this requires further consideration.  
 
Our most intriguing finding came from the ‘anxiety’ assessing tasks. First, the 8 and 15-
month old AppNL-F mice displayed unaltered locomotion and no difference in anxiety-
like behaviour in the open field and the elevated plus-maze relative to the wild-type 
control mice.  This is currently the first study to report on open field and elevated plus-
maze behaviours in the AppNL-F mice. Further studies are necessary in order to 
determine whether this result replicates across laboratories. In contrast, the 8-month 
old AppNL-G-F mice combined an ostensibly anxiogenic open field profile with an 
ostensibly anxiolytic plus-maze profile. This ostensibly anxiolytic plus-maze profile 
persisted in the 15-month old AppNL-G-F mice. We confirmed that these findings were 
not based on changes in locomotion (albeit there was a small degree of hyperactivity in 
the open field at 15-months) or general exploratory behaviour. Furthermore, in each 
instance, the significant change in behaviour observed in the AppNL-G-F mice was, in 
addition, relative to the AppNL-F mice.  
 
Three studies have investigated open field locomotion and anxiety in the AppNL-G-F 
mice. In each study methods were broadly consistent but not identical to our study; 
inter-laboratory differences in open field method are indeed common. Whyte et al. 
(2018) observed in 6-month old male AppNL-G-F mice significantly fewer zone entries and 
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significantly less distance travelled compared to wild-type control mice, whereas 
Mehla et al. (2019) observed no difference in these behaviours between the male AppNL-
G-F mice aged 3, 6, 9 and 12 months and wild-type control mice. Latif-Hernandez et al. 
(2017) also found no difference in distance travelled between female AppNL-G-F mice 
aged 3, 6 and 10 months and age-matched AppNL mice. Whyte et al. (2018) measured 
open field locomotion for only 5 minutes, which may explain the discrepancy between 
studies; however, we did not observe in our study any difference in the distances 
travelled within the first 5-minute time block. Together, these studies indicate that the 
AppNL-G-F mice have unaltered locomotion in the open field from 3 to 6 months, some 
evidence of hypo-activity at 6 months, normal locomotion from 8 to 10 months, and a 
degree of hyperactivity at 15-months. With regard to open field anxiety as measured by 
the number of entries and time in the centre of the apparatus, there appears to be some 
evidence that the AppNL-G-F mice display an ostensibly anxiogenic open field profile that 
is restricted to the 6 and 8-month age point. Mehla et al. (2019) found no evidence of 
altered anxiety-like levels in AppNL-G-F mice aged 3, 6, 9 or 12 months, nor did Whyte et 
al. (2018) at 6 months. Latif-Hernandez et al. (2017) did observe anxiety-like behaviour 
in the AppNL-G-F mice at 6 months, but not 3 or 10 months. Our results indicate an 
ostensibly anxiogenic open field profile at 8 months, but not 15 months. Thus, there is 
some evidence for the presence of an anxiogenic-like open field profile in the AppNL-G-F 
mice between the ages of 6 and 8 months. However, open field behaviour is reportedly 
variable and viewed as a less reliable measure of rodent anxiety compared to the 
elevated plus- maze (Prut & Belzung, 2003; Carola et al., 2002; Walsh & Cummins, 
1976).  
 
We observed an ostensibly anxiolytic plus-maze profile in the 8 and 15-month old 
AppNL-G-F mice as described by an increased amount of time on and number of entries 
into the open arms; this behaviour was not explained by altered locomotion or low 
levels of exploratory behaviour. We anticipated to some degree an altered plus-maze 
profile given that the hippocampus and amygdala are affected early in people with AD 
pathogenesis (Poulin et al., 2011) and play a prominent role in rodents’ response to 
anxiogenic stimuli (McHugh et al., 2004; Davis, 1992). Several other AD mouse models 
exhibit increased open arm activity in the plus-maze (Webster et al., 2014; Lalonde, 
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Fukuchi & Strazielle, 2012), and our results are broadly similar to the two studies that 
have reported elevated plus-maze behaviour in the AppNL-G-F mice. Latif-Hernandez et 
al. (2017) observed ostensibly anxiolytic behaviour in the plus-maze in 3 and 6-month 
old female AppNL-G-F mice, but not 10-month old AppNL-G-F female mice. Latif-Hernandez 
et al. (2017), citing Shoji et al. (2016), attributed this latter finding to the aging of the 
control mice (AppNL) that are on a C57BL/6 background. Sakakibara et al. (2018) 
reported a non-significant anxiolytic-like plus-maze profile in male AppNL-G-F mice aged 
6-9 months and 15-18 months, and this was relative to AppNL and wild-type control 
mice; the difference was more pronounced relative to the AppNL mice. Interestingly, 
when the AppNL-G-F mice in Sakakibara et al. (2018) were re-exposed to the plus-maze 
they displayed a significant ostensibly anxiolytic profile that the authors noted as 
highly unusual (Schnieder et al., 2011; File 1993); this result was more pronounced 
relative to the wild-type control mice. Given that an ostensibly anxiolytic plus-maze 
profile is commonly observed in AD mice that overexpress APP and exhibit Aβ 
plaques (Lalonde, Fukuchi & Strazielle, 2012), and that we observed anxiolytic-like 
behaviour in the plus-maze in the AppNL-G-F mice only and not the AppNL-F mice (which 
have very few Aβ plaques), it suggests that this behavioural finding may indeed be 
associated with the aberrant accumulation of Aβ plaques as opposed to the artifacts 
associated with APP overexpression.     
 
It is possible that the increased open arm activity observed in the 8 and 15-month old 
AppNL-G-F mice reflects a disinhibtion-like phenotype, which has been suggested by 
Latif-Hernandez et al. (2017), and also by Ognibene et al. (2005) in a study on Tg2576 
mice. Disinhibition is a well-known and equally distressing behavioural feature of AD 
(Zhao et al., 2016; Steinberg et al., 2008; Lesser & Hughes, 2006; Chung & Cummings, 
2000; Mega et al., 1996). It could be manifested within the current study as a failure to 
inhibit the choice to enter the open arms. Similarly, it may indicate a behavourial 
phenotype of impulsivity (Kishikawa et al., 2014; Pawlak et al., 2012; Langen & Dost, 
2011; Ueno et al., 2002). Masuda et al. (2016) reports impulsive-like behaviour in the 
AppNL-G-F mice using different paradigms. Given the lack of specific data in our study to 
speak to a disinhibition hypothesis, further conclusions cannot be drawn. However, 
this is a key finding of this chapter that we hope will facilitate future research 
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initiatives. Furthermore, we encourage the use of a wider array of behavioural tests in 
order to more precisely characterize social and anxiety-like behaviours in the APP 
knock-in mice, in addition to engaging in enhanced analyses of behaviour in the 
paradigms reported herein. For example, measuring behaviour such as rearing in the 
open field or stretch-attend postures in the elevated plus-maze may enhance 
behavioural characterizations (Carobrez & Bertoglio, 2005; Choleris et al., 2001).   
 
To summarize, in this chapter we extended the behavioural profile of male and female 
homozygous AppNL-F and AppNL-G-F mice in an age-dependent manner (8 and 15-
months) and explored behaviours that are reminiscent of the anxiety and social 
withdrawal symptoms observed in AD patients. The AppNL-F and AppNL-G-F mice 
displayed intact sociability with a minor impairment in preference for social novelty at 
the 8-month age point that was not explained by a reduced willingness to engage in 
social exploration. Interest in a social odour was significantly reduced in the 8-month 
old female AppNL-G-F mice, and mildly reduced in the 15-month old AppNL-F and AppNL-G-
F mice, and this was not explained by a general olfaction deficit. Why for example the 
15-month old APP knock-in mice had intact sociability and preference for social 
novelty but a minor deficit in social olfaction is unclear and deserves further attention. 
The most salient behavioural feature to emerge from this study was the disinhibitory 
tendencies observed in the 8 and 15-month old AppNL-G-F mice in the elevated plus-
maze. This finding replicates previous studies on the AppNL-G-F mice, and indicates that 
AppNL-G-F mice may enable the modeling of the neurobiological links between 
disinhibition-type behaviour and AD. Future studies may benefit by directly testing 
this hypothesis. We now turn to our DTI analysis of the ex vivo AppNL-F and AppNL-G-F 









CHAPTER - 3 
DIFFUSION TENSOR IMAGING OF THE AppNL-F and AppNL-G-F MOUSE BRAIN  
 
Diffusion-weighted MR imaging provides neuroscientific and clinical imaging data by 
sensitizing magnetic field gradients applied in multiple directions to the diffusion 
properties of tissue water (Alexander et al., 2007; Le Bihan et al., 2001). Brownian 
motion can describe the random movement of water molecules in neural tissue. When 
water is unconstrained, the direction of motion in a given molecule is random and is 
said to be isotropic. In tissue water, the Brownian motion of water is impeded by cell 
membranes, and is said to be anistropic. Information from the diffusion-weighted 
images can be mathematically modeled to extract the diffusion tensor, which provides 
quantitative measures of the orientation and magnitude of water diffusion at each 
voxel. The modeling of this displacement of water molecules in a multi-dimensional 
feature space provides insight into the microstructural properties of neural tissue, and 
has increased potential to distinguish differences in neural architecture within and 
between subjects (Le Bihan et al., 2015; Basser et al., 1994).  
 
DTI is increasingly being applied in AD research based on its enhanced sensitivity to 
capture early neurodegenerative related changes that predate the macrostructural 
changes observable with conventional volumetric techniques (Weston et al., 2015). AD 
has a long latency period, during which time there is progressive accumulation of 
molecular pathology followed by irreversible neuronal damage (Jack et al., 2018). 
Detection of this insidious, pre-symptomatic neurodegenerative change may prove 
useful as a biomarker of AD (Weiner et al., 2017; Mattson et al. 2015; Nir et al., 2013). 
Thus, DTI may be a promising tool in identifying individuals at risk for developing 
AD. For example, Douaud et al. (2013) and Kantarci et al. (2005) demonstrated that 
increased MD in grey matter predicted conversion from MCI to AD.  
 
The aim of this chapter is to identify whether the AppNL-F and/or AppNL-G-F mice enable 
modeling of the neurobiological links between emergent anxiety and social withdrawal 
in AD by characterizing DTI-derived neuropathology in brain regions thought to 
underlie these symptoms. As demonstrated by our behavioural results and other 
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published data, neither the AppNL-F nor the AppNL-G-F mouse exhibit any notable increase 
in anxiety-like behaviour, and therefore may not enable the modeling of the 
neurobiological basis of anxiety in AD. Alterations in social behaviour were mild and 
restricted to non-significant changes in preference for social novelty that was not 
explained by a reduced willingness to approach a conspecific. These results were also 
in line with other published data on the AppNL-G-F mice, and indicate that the AppNL-F 
and AppNL-G-F mice are not suitable for modeling the neurobiological links associated 
with social withdrawal in AD. Nevertheless, the original neural regions of interest 
remain relevant to our diffusion tensor study.  
 
The orbitofrontal and anterior cingulate cortices are thought to underlie decision- 
making processes (Dias, Robbins & Roberts, 1996), and thus, neuropathology in these 
regions may relate to the anxiolytic-like behaviour displayed by the AppNL-G-F mice in 
the elevated plus-maze and help identify whether these mice enable the modeling of 
the neurobiological links between disinhibition-type behaviour and AD. Secondarily, 
Bannerman et al. (2004) evidenced a role of the ventral hippocampus in mediating 
behaviour in the elevated plus-maze; lesions to the ventral hippocampus reduced 
anxiety-like behaviour and promoted exploration of the open arms of the maze.  
Thirdly, and irrespective of the behavioural results, by applying DTI to the APP knock-
in mice we can characterize early neurodegenerative changes in the absence of 
potential artifacts associated with earlier transgenic mice. Moreover, comparative 
analysis of the AppNL-F and AppNL-G-F mice may offer insight into the differential effects 
of soluble Aβ (as in the AppNL-F) and insoluble Aβ (as in the AppNL-G-F) on the 
microstructural integrity of neural tissue. To summarize, the three aims of this chapter 
are (1) to characterize in the APP knock-in mice the microstructural properties of the 
neural tissue within brain regions commonly affected in AD, which are the 
orbitofrontal frontal and anterior cingulate cortices, the amygdala and the ventral and 
dorsal hippocampus; (2) identify the differential effects, if any, of soluble Aβ and 
insoluble Aβ on tissue diffusion properties; and (3) identify whether the AppNL-G-F mice 
enable the modeling of the neurobiological links between disinhibition-type behaviour 
and AD.  
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3.2 Materials and Methods 
3.2.1 Animals  
Following behavioural testing, mice were placed into a surgical plane of anaesthesia 
using an intraperitoneal injection of sodium pentobarbital, and then transcardially 
perfused with 0.1 M phosphate-buffered saline (PBS) followed by a solution of 4% 
paraformaldehyde (PFA) / 0.1 M PBS. The brains were rapidly removed from the skull 
and post-fixed in 4% PFA / 0.1 M PBS for a minimum of 48 h prior to imaging.              
Forty-eight whole-brains were imaged in total to include 8 brains (4 male/4 female) per 
genotype (wild-type / AppNL-F / AppNL-G-F), per age group. The mean ages of these mice 
at the time of euthanasia were 9.3 months (±0.45) and 16.9 months (±0.32).  
3.2.2 MRI Data Acquisition 
MRI data were acquired at the University of Leeds (UK) on a vertical 9.4 Tesla 
spectrometer (Bruker AVANCE™ II NMR; Ettlingen, Germany) equipped with an  89 
mm wide bore, 3 radio frequency channels with digital broadband frequency synthesis 
(6-620 MHz), and an imaging coil with a diameter of 25 mm for hydrogen (1H). Each 
brain was placed into a 15 ml conical tube with a custom designed holding platform 
and immersed in Fomblin Y-1800 (Sigma-Aldrich, UK); a proton-free fluid used to 
mitigate magnetic susceptibility distortions that also prevents dehydration (Miller et 
al., 2011). For each brain, three-dimensional diffusion-weighted images were acquired 
using a DT-MRI protocol with an echo time (TE) of 35 ms, repetition time (TR) of 700 
ms, and 1 signal average. The field of view was set at 168 x 128 x 96, with an achieved 
cubic resolution of 62.5 µm/pixel and a diffusion-weighting factor of b = 1625 s/mm2. In 
each scan, the diffusion-sensitizing gradients were applied in 30 non-collinear, non-
coplanar directions, baseline volumes (b=0 images) were collected, and the total 
imaging time was 20 h.  
 
3.2.3. MRI Data Processing  
The diffusion-weighted images were reconstructed from the Bruker 2dseq file on a 
personal computer using DSI Studio (http://dsi-studio.labsolver.org), an open-source 
software tool for diffusion MR image analysis. Parsing of the raw data was semi-
automated and unwanted background, setting a threshold, smoothing of the data and 
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definition of tissue boundaries were completed prior to calculating the tensor. The 
diffusion-weighted images were then reconstructed by selecting the DTI reconstruction 
method, a model-based algorithm introduced by Basser, Mattiello and Le Bihan (1994), 
which assumes the velocity of water diffusion as a three-dimensional Gaussian 
distribution, and the corresponding diffusion tensor as a 3 x 3 covariance matrix 
estimated at each voxel in the brain (O’Donnell & Westin, 2011; Le Bihan et al., 2001). 
The DTI reconstruction method performs eigenanalysis on the calculated tensor, 
decomposing the matrix into its eigenvalues and eigenvectors (Figure 3.1). The 
eigenvalues provide information on the rate of diffusion whereas the eigenvectors 
describe the orientation of diffusion (Jiang et al., 2006). Various mathematical formulas 
as a function of the eigenvalues and vectors form the basis of quantitative DTI derived 
scalar indices.  
 
 
Diffusion along a group of fiber tracts.    
In the laboratory frame of reference (x-
y-z) diffusion coefficients are measured 
in a minimum of six unique directional 
combinations described by the diffusion 
tensor, D.   
The simpler frame of reference is to 
centre the coordinate system within 
each voxel with the axes parallel and 
tangent to the principal directions of 
diffusion. This is represented as an 
ellipsoid; the off-diagonal elements of 
the tensor disappear.  
The diffusion ellipsoid has three unit 
vectors (ε1, ε2, ε3), called eigenvectors 
with corresponding lengths (λ1, λ2, λ3)  
called eigenvalues.  
.  	
	 	 	 Dxx	 Dxy	 Dxz	
	 D =	 Dyx	 Dyy	 Dyz	
	 	 	 Dzx	 Dzx	 Dzz		
	 	 	 λ1	 0	 0	
	 Λ =	 0	 λ2	 0	
	 	 	 0	 0	 λ3		
Figure 3.1. The diffusion tensor model. The model summarizes diffusion-weighted imaging data collected in 
several directions. The rate and orientation of tissue water diffusion within each voxel is the integration of 
these measurements. The diffusion tensor is a symmetric 3 x 3 matrix, and it can be described by its 
eigenvectors (ε1, ε2, ε3) and eigenvalues (λ1, λ2, λ 3). A diffusion tensor is visualized using an ellipsoid, with 
the size, shape and orientation of each ellipsoid dictated by the eigenvalues and eigenvectors of the 
corresponding diffusion tensor. The three orthogonal axes of the tensor coincide with the three eigenvectors, 
and the length of the three axes is proportional to the three eigenvalues (Soares et al., 2013). Pictorial 
representation and captions were sourced from www.mriquestions.com.  	
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3.2.4 Quantitative DTI Scalar Indices  
We characterized the microstructural integrity of neural tissue using scalar measures 
derived from the calculated tensor. These scalar indices included the axial diffusivity 
(AxD), radial diffusivity (RD), mean diffusivity (MD) and fractional anisotropy (FA). 
The mathematical calculations are shown below. AxD, which is denoted by λ1, 
quantifies how fast the water diffuses along the principal axis of diffusion, and RD, 
which is the average of the secondary (λ2) and tertiary (λ3) eigenvalues, quantifies how 
fast the water diffuses perpendicular to λ1. MD provides an average of the three 
eigenvalues to describe the overall diffusion rate of tissue water. Note that diffusivity 
in DSI Studio has a unit of 10-3 mm2/s. FA quantifies the fraction of diffusion that is 
anisotropic by comparing the relative difference between the largest eigenvalue (λ1) to 
λ2 and λ3. It describes in part the shape of diffusion, is rotationally invariant and ranges 
from a value of 0 to 1. Zero indicates perfect isotropic diffusion (equal in all directions) 
and is represented as a sphere (λ1=λ2 =λ3), whereas total anisotropic diffusion would 
have a value of 1 indicating that there was no diffusivity perpendicular to the principal 
axis of diffusion. Virtually all tissue will demonstrate some degree of anisotropy, given 
that physical barriers such as cellular membranes will naturally restrict the diffusivity 
of tissue water (Basser & Pierpaoli, 1996).  
 
 
  AxD =   λ1       
RD = 








√3  √ (λ1 – λ)2 + (λ2 – λ)2  + (λ3 – λ)2 
√2  √ λ12 + λ22 + λ32 
 
               where    







3.2.5 Region of Interest Identification and Segmentation  
Our approach was to undertake an a posteriori analysis of the microstructural integrity 
of neural tissue within the orbitofrontal and anterior cingulate cortices, the amygdala, 
and the dorsal and ventral hippocampus, brain regions that have been identified by 
previous literature as being relevant to anxiety and social behaviour (see chapter 1). To 
perform statistical analysis, we extracted the MD and the mean AxD, RD, and FA from 
five manually drawn regions of interest (ROI) for each reconstructed brain (Figure 3.3). 
The DTI reconstruction allows for an interactive 2D visualization of grayscale image 
contrasts of the various scalar indices. Using the Paxinos and Franklin (2012) mouse 
brain atlas as a reference, the FA map was looped through in orthogonal views of the 
coronal plane until a target coronal slice was identified. The ROI was then manually 
drawn on the target slice using the atlas as reference (Figure 3.4). The summary 
measures were then calculated and extracted semi-automatically from 300 µm of tissue; 
this included the slice on which the ROI was drawn, plus the slice immediately anterior 







Figure 3.3. ROI for diffusion tensor analysis. Images from the Paxinos and Franklin (2012) mouse brain atlas.    
The dotted line represents the intended boundary for the manually drawn ROI within (A) Orbitofrontal Cortex                       





Figure 3.4. Manually drawn ROI. Representative coronal sections of a DTI-scanned brain as displayed in 
DSI Studio. Reconstructed brains were viewed as an FA map. With the aid of the Paxinos and Franklin 
(2012) mouse brain atlas, the FA map was looped through in orthogonal views of the coronal plane until 
a target slice was identified. The author then carefully delineated the ROI within each hemisphere. 
Highlighted areas exemplify a manually drawn ROI for (A) Orbitofrontal Cortex (~ Bregma 2.58 mm), 
(B) Anterior Cingulate Cortex (~ Bregma 1.18 mm), (C) Dorsal Hippocampus (~ Bregma -1.94 mm),      






3.2.6 Data Analysis  
Data sets were initially analyzed using a mixed model repeated-measures ANOVA 
with hemisphere as the within-subjects factor and genotype as the between-subjects 
factor. Simple main effects analyses are reported where hemisphere and genotype 
interact, using either paired t-test to assess differences between hemispheres within 
genotype, or one-way ANOVA to assess differences between genotypes within the left 
and right hemispheres. Non-significant effects of hemisphere and non-significant 
interactions between hemisphere and genotype are reported in Table 3.1. In the absence 
of an interaction, the data was collapsed across hemispheres and a one-way ANOVA 
was used to assess the differences between genotypes. A one-way ANOVA was used in 
lieu of the between-subjects output in the repeated-measures ANOVA in order to 
accurately assess homoscedasticity, and subsequently, to select the appropriate 
correction for pairwise comparisons. A Welch one-way ANOVA with Games-Howell 
comparisons is reported where data violated homoscedasticity, otherwise the Tukey 
pairwise comparisons are reported. We did not investigate for interactions between 
genotype and sex due to the small sample sizes. The author performed all statistical 
analyses using IBM™ SPSS© v.22.0 with the critical α level set to p ≤ 0.05. The author 
designed the graphs to illustrate the underlying distribution of data, and used 
GraphPad Prism™ v.8.2.1. Statistical significance within figures is illustrated as  *(p ≤ 














3.3 Results  
3.3.1 9-month age point 
3.3.1.1 Orbitofrontal Cortex (9 months) 
Results are illustrated in Figure 3.5A-D. There were no effects of hemisphere or 
interactions between hemisphere and genotype on the DTI derived indices for the 
orbitofrontal cortex. There was an effect of genotype on all four diffusion properties: 
MD (F(2,21) = 6.67, p = 0.006), FA (F(2,21) = 3.05, p = 0.049), AxD (F(2,21) = 7.13, p = 0.004) and 
RD (F(2,21) = 5.87, p = 0.009). The MD, AxD and RD were significantly increased in the 
AppNL-G-F mice compared with the wild-type (p = 0.015, 0.020, 0.017) and the AppNL-F 
mice (p = 0.013, 0.006, 0.022), respectively. The FA was significantly increased in the 
AppNL-G-F mice compared to the AppNL-F mice (p = 0.049), but not the wild-type mice (p = 
0.831). There were no differences in tissue diffusion properties between the AppNL-F 


















                     Figure 3.5. Tissue diffusion properties within the orbitofrontal cortex at 9-months.  

























































































3.3.1.2 Anterior Cingulate Cortex (9 months) 
Results are illustrated in Figure 3.6A-D. The FA within the anterior cingulate cortex 
was similar between genotypes (F(2,21) = 0.87, p = 0.433). An effect of genotype was 
indicated for the MD (F(2,21) = 4.28, p = 0.028), the AxD (F(2,21) = 4.90, p = 0.018) and the RD 
(F(2,21) = 3.67, p = 0.043). Pairwise comparisons confirmed a marginal increase in MD 
within the AppNL-G-F mice compared with the wild-type mice (p = 0.051), and a 
significantly higher AxD in the AppNL-G-F mice compared with the wild-type mice (p = 
0.043). For RD, the pairwise comparisons did not reach statistical significance. The 
AppNL-G-F mice also had a significantly higher MD (p = 0.047) and AxD (p = 0.027) 
compared with the AppNL-F mice. There were no differences between the AppNL-F mice 
and the wild-type mice on any of the tissue diffusion properties. Note that the 



















                     Figure 3.6. Tissue diffusion properties within the anterior cingulate cortex at 9-months.  






























































3.3.1.3 Amygdala (9 months) 
Results are illustrated in Figure 3.7A-D. Hemisphere and genotype interacted on the 
FA (F(2,21) = 5.66, p = 0.011), and RD (F(2,21) = 4.52, p = 0.023). There was a significant 
difference in FA between the left and right hemisphere within the wild-type mice (t(7) = 
2.67, p = 0.032). The simple main effects analyses for RD were all non-significant. The 
tissue diffusion properties within the amygdala were similar across genotypes: MD 
(F(2,21) = 0.33, p = 0.721), FA (F(2,21) = 0.12, p = 0.888), AxD (F(2,21) = 0.43, p = 0.656) and RD 






















                             Figure 3.7. Tissue diffusion properties within the amygdala at 9-months.  























































































3.3.1.4 Dorsal Hippocampus (9 months) 
Results are illustrated in Figure 3.8A-D. There were no effects of hemisphere or 
interactions between hemisphere and genotype on the DTI derived indices for the 
dorsal hippocampus. Neither the MD (F(2,21) = 1.29, p = 0.294), the FA (F(2,21) = 0.27, p = 
0.792) nor the RD (F(2,21) = 0.70,    p = 0.507) differed between genotypes. There was an 
effect of genotype on AxD (F(2,21) = 3.88, p = 0.037). This was due to a significantly higher 
AxD in the AppNL-G-F mice compared with the wild-type mice (p = 0.030). The AxD did 
not differ between the AppNL-G-F and AppNL-F mice (p = 0.238), nor the wild-type and 






















                    Figure 3.8. Tissue diffusion properties within the dorsal hippocampus at 9-months.  















































































3.3.1.5 Ventral Hippocampus (9 months) 
Results are summarized in Figure 3.9A-D. The FA (F(2,21) = 2.07, p = 0.151) and AxD 
(F(2,21) = 2.29, p = 0.125) was similar between genotypes. The MD was significantly 
increased (F(2,21) = 5.64, p = 0.011) in the AppNL-G-F mice compared to the wild-type mice 
(p = 0.015) and the AppNL-F mice (p = 0.035); wild-type vs. AppNL-F mice (p = 0.914). The 
RD was significantly higher in the left vs. the right hemisphere (F(1,21) = 4.35, p = 0.049; 
MD = 0.004 ±0.002), and the RD was significantly increased (F(2,21) = 8.17, p = 0.002) in the 
AppNL-G-F mice compared with the wild-type mice (p = 0.008) and the AppNL-F mice (p = 





















                     Figure 3.9. Tissue diffusion properties within the ventral hippocampus at 9-months.  



















































































3.3.2 17-month age point 
3.3.2.1 Orbitofrontal Cortex (17 months) 
Results are illustrated in Figure 3.10A-D. There were no effects of hemisphere or 
interactions between hemisphere and genotype. FA was similar across genotypes (F(2,21) 
= 0.18, p = 0.838), and AxD was marginally significant (F(2,12.30) = 3.80,  p = 0.052; AppNL-G-F  
> wild-type, p = 0.051). There was an effect of genotype on MD (F(2,13.44) = 4.27, p = 0.037) 
and RD (F(2,13.06) = 3.87, p = 0.048). Compared with the wild-type mice, MD was 
significantly higher in the AppNL-F (p = 0.049) and AppNL-G-F mice (p = 0.038) but did not 
differ between the two (p =1.000), and RD was significantly higher in the AppNL-G-F mice 


















                       
                     
                     Figure 3.10. Tissue diffusion properties within the orbitofrontal cortex at 17-months.  


















































































3.3.2.2 Anterior Cingulate Cortex (17 months) 
Results are illustrated in Figure 3.11A-D. There were no effects of hemisphere or 
interactions between hemisphere and genotype. There was an effect of genotype on FA 
(F(2,21) = 5.09, p = 0.016). FA was significantly lower in the AppNL-G-F mice compared with 
the wild-type (p = 0.021) and AppNL-F mice (p = 0.046); there was no difference on FA 
between the wild-type and AppNL-F mice (p = 0.931). There were no differences between 
genotypes in either MD (F(2,21) = 1.63, p = 0.219) or AxD (F(2,12.95) = 0.530, p = 0.601). For 
RD, although there was an effect of genotype (F(2,11.23) = 3.95, p = 0.050), the pairwise 






















                 Figure 3.11. Tissue diffusion properties within the anterior cingulate cortex at 17-months.  

















































































3.3.2.3 Amygdala (17 months) 
Results are illustrated in Figure 3.12A-D. There were no effects of hemisphere or 
interactions between hemisphere and genotype on the tissue diffusion properties 
measured within the amygdala. Furthermore, there were no significant changes 
between genotypes when assessing the MD of the amygdala tissue (F(2,21) = 0.66, p = 
0.524), the AxD (F(2,21) = 0.02, p = 0.985) or the RD (F(2,21) = 1.36, p = 0.280).  FA was 
marginally significant (F(2,21) = 3.37, p = 0.054), which was driven by the lower FA in the 






















                             Figure 3.12. Tissue diffusion properties within the amygdala at 17-months.  





















































































3.3.2.4 Dorsal Hippocampus (17 months) 
Results are illustrated in Figure 3.13A-D. There was a marginal effect of hemisphere 
when assessing RD, F(2,21) = 4.07, p = 0.056 (L > R), otherwise, there were no effects of 
hemisphere or interactions between hemisphere and genotype. The FA of the tissue 
within the dorsal hippocampus was similar across genotypes (F(2,21) = 2.02, p = 0.158). 
However, there were differences in MD (F(2,21) = 5.95, p = 0.009), AxD (F(2,21) = 4.64, p = 
0.021) and RD (F(2,21) = 6.21, p = 0.008). The AppNL-G-F mice had a significantly higher MD 
(p = 0.020) and RD (p = 0.012) in comparison to the wild-type mice, and a significantly 
higher MD (p = 0.017), RD (p = 0.022) and AxD (p = 0.023) in comparison to the AppNL-F 
mice. There were no significant changes in tissue diffusion properties between the 




















                   Figure 3.13. Tissue diffusion properties within the dorsal hippocampus at 17-months.  























































































3.3.2.5 Ventral Hippocampus (17 months) 
Results are illustrated in Figure 3.14A-D. MD and AxD were significantly higher in the 
left hemisphere compared to the right hemisphere. Hemisphere and genotype 
interacted on RD (F(2,21) = 4.96, p = 0.017) due to a significant difference within the 
AppNL-F mice (t(7) = 3.68, p = 0.008; L > R), and a significantly higher RD within the left 
hemisphere of the AppNL-G-F mice relative to the wild-type mice (F(2,11.69) = 6.67, p = 0.012; 
p = 0.006). There was no effect of genotype on either FA (F(2,21) = 2.22, p = 0.134) or RD 
(F(2,10.58) = 3.74, p = 0.059). There were main effects of genotype on MD (F(2,10.39) = 4.68, p = 
0.036) and AxD (F(2,12.56) = 5.83, p = 0.016). The AppNL-G-F mice had a significantly higher 
MD compared with the wild-type mice (p = 0.049) and AppNL-F mice (p = 0.048). For 
AxD, there was a significant increase within the AppNL-G-F mice compared with the 


















                     
                    Figure 3.14. Tissue diffusion properties within the ventral hippocampus at 17-months.  




















































































3.4 Materials, Methods & Results (Immunohistochemistry)  
3.4.1 Animals 
Following ex vivo MR imaging, 10 brains were selected from the younger set of mice for 
immunohistochemical analysis: wild type (n=2; 1 male), AppNL-F (n=4; 2 male) and 
AppNL-G-F (n=4; 2 male). The tissue from the older cohort was preserved for future 
research initiatives, and was thus unavailable to the author for immunostaining.   
3.4.2 Tissue sampling  
The brains were rinsed of Fomblin Y-1800 using repeated PBS washes aided by 
agitation from a laboratory rocker, then cryoprotected by immersion in a solution of 
30% sucrose / 0.1M PBS and stored at 4 °C for a minimum of 72 h. Immediately prior to 
cryosectioning, the olfactory bulb and cerebellum were removed with a perpendicular 
cut to the rostral isocortex and inferior colliculus using a single edge razor blade. The 
brain was then hemisected along the longitudinal fissure to separate the left and right 
hemispheres. With the aid of a brain matrix, three slices were made to the left 
hemibrain at 3 mm, 5 mm and 7 mm from the rostral-most boundary. The sections 
were placed on individual blocks of frozen optimal cutting temperature compound 
(OCT), covered with liquid OCT, and then placed in the cryostat-microtome to freeze at 
-19 °C for 30 minutes. The OCT embedded tissue was then sliced into 30 µm coronal 
sections with the cryostat-microtome set to -19 °C. Tissue samples corresponding to the 
same Bregma coordinates reported in the DTI analysis were taken and placed into 
multi-well culture plates filled with PBS.  
3.4.3 Immunohistochemical procedure 
Immunohistochemical detection of extracellular Aβ deposits was performed on free-
floating 30 µm coronal tissue slices following the protocol outlined in Ly, Cai and Song 
(2011). At each stage of the process the culture plate was gently shaken on a laboratory 
rocker for the time specified. All washes were done using a solution of 0.3% v/v Triton-
X 100 in PBS (Tx-PBS), and all steps were carried out at room temperature unless noted 
otherwise. The tissue was first placed in a solution of 88% formic acid / 12% distilled 
H2O for 15 minutes to perform antigen retrieval (i.e., to unmask the antigenic epitope 
due to the cross-link effect of aldehyde fixatives). The tissue was then washed 3x for 5 
minutes. The tissue was next incubated with 0.5% H2O2 in Tx-PBS for 30 minutes to 
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eliminate endogenous peroxidase activity and prevent non-specific background 
staining during chromogenic detection. The tissue was next incubated with 2% bovine 
serum albumin (BSA) (Acros Organics, UK) in Tx-PBS for 1 h to prevent the non-
specific binding of antibodies. The tissue was next incubated overnight at 4 °C with 
monoclonal 6E10 primary antibody (BioLegend; San Diego, USA) in a concentration of 
1:500 [6E10 to 2% BSA / Tx-PBS]. Anti-Aβ 6E10 reacts to amino acid residues 1-16 of 
Aβ, and binds to abnormally processed isoforms and its precursor form. The tissue was 
then washed 3x for 10 minutes. The tissue was next incubated for 2 h with biotinylated 
goat anti-mouse immunoglobulin (IgG) secondary antibody (Vector Laboratories, UK) 
in a concentration of 1:500 [IgG to 2% BSA/ Tx-PBS]. The tissue was then washed 3x for 
10 minutes. The tissue was next incubated for 30 minutes with Avidin-Biotin Complex 
(VECTASTAIN ELITE® ABC Kit; Vector Laboratories, UK) to amplify the target antigen 
signal [1 drop Reagent A to 1 drop Reagent B to 2.5 ml of 2% BSA / Tx-PBS]. The tissue 
was then washed 3x for 10 minutes. The tissue was next incubated for 5 minutes (no 
shaking) with 3,3'-diaminobenzidine (DAB) (Vector Laboratories, UK) in order to 
visualize the Aβ immunostained profiles [1 drop DAB to 1 drop peroxidase to 2 drops 
buffer to 2.5 ml of distilled H2O]. The tissue was then washed 3x for 10 minutes and 
mounted onto gelatin-coated slides. The slides were dehydrated in a drying oven for a 
minimum      of 1 h, and then cleared twice for 5 minutes with Xylene (Fisher Chemical, 
UK) and cover slipped with DPX Mountant medium (Sigma-Aldrich, UK). Lastly, 
digital photomicrographs were acquired with a Leica DM2000 light microscope at 40x 
magnification using the Leica application suite (LAS) v4.12.0.  
3.4.4 Immunohistochemistry Results  
Immunohistochemistry was performed using the anti-Aβ 6E10 to visualize the extent 
of Aβ plaques within orbitofrontal and anterior cingulate cortices, anterior amygdala 
and ventral and dorsal hippocampus of the wild-type, AppNL-F and AppNL-G-F mice. Aβ 
deposition was qualitatively assessed and compared between genotypes. As shown in 
figure 3.15, the AppNL-G-F mice accumulated vast amounts of Aβ plaques in all ROI by 9 
months of age, whereas the AppNL-F mice accumulated very few plaques at this age 



































Figure 3.15. Aβ plaques in the APP knock-in mice. Representative photomicrographs illustrating the extent 
of Aβ deposition in the wild-type, AppNL-F and AppNL-G-F mice (~9 months old), visualized with 6E10. Aβ 
plaques were easily observed throughout the AppNL-G-F brain, and to a far lesser extent in the cortex of the 
AppNL-F brain (black arrow indicates an Aβ plaque). Aβ plaques were not observed in the wild-type mice. 
The author performed all tissue preparation, immunohistochemistry and imaging.  





















3.5 Discussion  
We performed ex vivo DTI on the brains of male and female AppNL-F and AppNL-G-F mice 
at ages 9 and 17-months in order to capture aspects of neuropathology that occur in 
regions traditionally associated with the early phases of AD, and the social and 
anxiety-like behaviours investigated in this thesis. These neural regions were the 
orbitofrontal and anterior cingulate cortices, the anterior amygdala and the ventral and 
dorsal hippocampus. As this is the first study to apply DTI to these novel and much-
improved mouse models of AD, the principal aim in exploring these neural regions for 
potential microstructural change was to help facilitate future research endeavours 
employing these model mice. The more immediate aim was to identify a putative 
signature of neuropathology associated with the behavioural changes described in 
chapter 2. This is a topical initiative in AD research (Cuthbert, 2019; Lanctôt et al., 2017; 
Canevelli et al., 2016) and more generally psychiatric illness (Kas et al., 2019; Cuthbert 
& Insel, 2013), and is a necessary first step in identifying neural regions that warrant 
further investigating for underlying altered mechanisms.  
 
A key question is how the DTI-derived scalar indices relate to biological change, and 
how the differences and changes in biology influence each measure of diffusivity 
individually and as an accumulative pattern. There are currently no clear answers to 
these questions. As Le Bihan and Lima (2015) point out, exploiting the full potential of 
the DTI technique to obtain information on tissue microstructure will require more 
research on the mechanisms that govern diffusion of water in neural tissue. However, 
on the simplest level, it is understood that tissue hinders the diffusion of water. In 
white matter, where tissue is homogeneous and assumes a shape, the FA, MD, AxD 
and RD can reflect the degree of myelination, cell death and edema, axonal injury and 
demyelination, and loss of oligodendrocytes and reactive astrocytosis, respectively 
(Weiner, 2017). However, in grey matter, where net diffusion is not expected to 
conform to any one direction, the primary measure to probe tissue microstructure is 
MD (Weston, 2015; Alexander, 2007). As cellular microstructure breaks down and there 
are fewer obstacles to diffusion, MD is expected to increase. Conversley, cellular 
swelling or increased cellular density is expected to reduce MD. Previous studies on 
grey matter MD in AD report increases of hippocampal MD and whole brain grey 
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matter MD in participants with MCI as compared to matched controls (Fellgeibel et al., 
2004). Furthermore, increases in grey matter MD distinguished between MCI patients 
who later went on to develop AD and MCI patients that remained stable (Douaud et 
al., 2013; Scola et al., 2010). Thus, in line with most all other studies that apply DTI to 
the AD brain, we focus primarily on MD. However, FA, AxD and RD have been 
reported for completeness. 
The microstructural integrity of the five neural regions investigated was intact in the 9-
month old AppNL-F mice relative to the age-matched wild-type control mice. At the 17-
month age point, the MD was significantly increased in the orbitofrontal cortex of the 
AppNL-F mice compared with the age-matched wild-type control mice but not the 
AppNL-G-F mice. This was the only DTI-derived microstructural alteration found in the 
AppNL-F mice. This finding is not trivial and will be discussed in further detail. DTI-
derived microstructural alterations can precede overt behavioural change (Alexander 
et al., 2017; Ryan et al., 2013) and occur early in AD pathogenesis (Weiner et al., 2015). 
Thus, it was indeed possible that we would have observed greater change in the 
microstructural integrity of the neural tissue of the AppNL-F mice. Shah et al. (2018), 
using resting-state functional MRI (rsfMRI), detected hypersynchronized functional 
connectivity in AppNL-F mice as young as 3 months. BOLD functional connectivity was 
significantly increased in the hippocampal and frontal/cingulate networks, and there 
was hyposynchrony of BOLD functional connectivity at 7-months. Although our mice 
were at least 2 months older in age, this may suggest that measures of structural 
change derived from DTI data are not related to changes in BOLD functional 
connectivity. Nevertheless, given the minor AD-related pathology in these mice 
combined with the minor behavioural changes in preference for social novelty at the 8-
month age point and social olfaction at the 15-month age point, the limited DTI-
derived neuropathology is unsurprising. In contrast, there were DTI-derived 
abnormalities observed in the 9 and 17-month old AppNL-G-F mice. 
 
First, in regards to the anterior amygdala, we found no DTI-derived neuropathology in 
the 9 or 17-month old AppNL-G-F mice; however, FA was marginally decreased in the 17-
month old AppNL-G-F mice relative to the AppNL-F mice. Next, with respect to the DTI-
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derived neuropathology in the hippocampus of the 9-month old AppNL-G-F mice, the 
AxD was significantly increased in the dorsal region relative to the wild-type mice, and 
the MD and RD was significantly increased in the ventral region relative to the wild-
type mice and the AppNL-F mice. The 9-month old AppNL-G-F mice also exhibited a 
significantly increased MD, AxD and RD in the orbitofrontal cortex, and a marginally 
increased MD and significantly increased AxD in the anterior cingulate cortex, 
compared with the wild-type mice and the AppNL-F mice; the FA in the orbitofrontal 
cortex was significantly increased relative to the AppNL-F mice only. With respect to the 
DTI-derived neuropathology in the 17-month old AppNL-G-F mice, in the dorsal 
hippocampus, the MD, AxD and RD was significantly increased relative to the wild-
type mice and the AppNL-F mice. In the ventral hippocampus, the MD was significantly 
increased relative to the wild-type and the AppNL-F mice, whereas AxD was 
significantly increased relative to the AppNL-F mice only. Additionally, the 17-month old 
AppNL-G-F mice had a significantly higher MD and RD in the orbitofrontal cortex 
compared with the wild-type mice, and a significantly lower FA in the anterior 
cingulate cortex relative to the wild-type and AppNL-F mice.  
 
Changes in the rate of tissue water diffusion were far more common in the AppNL-G-F 
mice than the AppNL-F mice, and were always based on increased diffusivity. There was 
one change in FA, and that was a lower FA value in the anterior cingulate cortex of the 
17-month old AppNL-G-F mice relative to the wild-type and AppNL-F mice; there was a 
marginally lower FA value in the amygdala of the 17-month old AppNL-G-F mice relative 
to the AppNL-F mice. Nearly all of the same changes that occurred in the AppNL-G-F mice 
relative to the wild-type mice also occurred relative to the AppNL-F mice; the two 
exceptions were that there were no differences between the APP knock-in strains for 
the dorsal hippocampus at 9-months or the orbitofrontal cortex at 17-months. A key 
finding is that AppNL-G-F mice display DTI-derived neuropathology at 9-months and 17-
months, and these alterations occur in the same manner relative to the wild-type mice 
as they do the AppNL-F mice. In contrast, the AppNL-F mice do not exhibit DTI-derived 
pathology at 9-months, but do exhibit an increase in MD in the orbitofrontal cortex at 
17-months.  
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The most salient behavioural finding from chapter 2 was the increased open arm 
activity observed in the 8 and 15-month old AppNL-G-F mice that we suggest may 
represent a disinhibtion-like phenotype, in line with findings from Latif-Hernandez et 
al. (2017) and Ognibene et al. (2005). Disinhibition is a well-known, and equally 
distressing behavioural feature of AD (Zhao et al., 2016; Steinberg et al., 2008; Lesser & 
Hughes, 2006; Chung & Cummings, 2000; Mega et al., 1996). It could be manifested 
within the current study as a failure to inhibit the choice to enter the open arms. Based 
on a review by Bannerman et al. (2004), the hippocampus may function in part to 
compare different response alternatives and select optimal responses. In the case of an 
unconditioned test of anxiety like the elevated plus-maze, this involves selecting 
between conflicting approach and avoid responses. The plus-maze juxtaposes mice 
natural propensity to explore novel environments, such as the open arms of the maze, 
with mice propensity to avoid the open spaces in favour of the protected closed arms. 
Evidence from both rodents and humans suggests that the ventral hippocampus (or 
anterior in humans) plays a role in mediating these sorts of approach-avoidance 
conflict processing. Both McHugh et al. (2004) and Bannerman et al. (2002) 
demonstrated that lesions to the rat ventral hippocampus resulted in an anxiolytic-like 
elevated plus-maze profile, and Bannerman et al. (2004) draws associations between 
ventral hippocampus lesions and behavioural disinhibition and reduced anxiety. 
Intriguingly, we found DTI-derived neuropathology in the ventral hippocampus of the 
9 and 17-month old AppNL-G-F mice as described by significant increases in MD. It is 
possible that the DTI-derived neuropathology in the ventral hippocampus is linked to 
the ostensibly anxiolytic plus-maze profile observed in these mice. This behavioural 
result would also predict DTI-derived changes in the orbitofrontal cortex and anterior 
cingulate cortex.  
 
The anterior cingulate cortex is a brain region that has been well established with 
mediating anxiety/fear (Etkin, Egner & Kalisch, 2011; Davidson, 2002). Additionally, 
the anterior cingulate cortex and orbitofrontal cortex have a well-established link to 
behavioural decision making, especially for affective stimuli (Dias et al., 1996). 
Furthermore, Yu and Frank (2015) highlight how hippocampal-prefrontal cortex 
interactions in the rat could provide a neural substrate for deliberative decision- 
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making. With that in mind, the 9-month old AppNL-G-F mice had a significantly 
increased MD in the orbitofrontal cortex combined with a marginally increased MD in 
the anterior cingulate cortex. The 17-month old AppNL-G-F mice had a significantly 
increased MD in the orbitofrontal cortex combined with a significantly lower FA in the 
anterior cingulate. Interestingly, the 17-month old AppNL-F mice also displayed an 
increased MD in the orbitofrontal cortex, suggesting that this microstructural alteration 
emerges early in AD pathogenesis. Resting-stage functional MR imaging (rsfMRI) has 
shown that connectivity of the medial prefrontal cortex to other regions is abnormal in 
the 3-month old AppNL-G-F mice (but not 7-month or 11 month) with the anterior 
cingulate cortex being the most altered region (Latif-Hernandez et al., 2017). 
Furthermore, these areas are susceptible to degeneration in early AD pathology 
(Huang et al., 2002; Scheff and Price, 2001). Together, these results suggest that the 
AppNL-G-F mouse may enable modeling of the neurobiological links between emergent 
disinhibition-type behaviour and AD.  
 
A few observations are reported with regard to the immunohistochemical analysis. Aβ 
deposition does not appear to be sufficient to cause DTI-derived neuropathology, 
otherwise the author is unsure how to reconcile the fact that the amygdala remained 
unaffected in the 9 and 17-month old AppNL-G-F mice despite similar amounts of Aβ 
deposition compared to regions that did display marked changes in DTI-derived 
neuropathology (at least by our assessment; and Hamaguchi et al., 2019; Saito et al., 
2014). However, given that we do see marked neural microstructural change in the 9-
month old AppNL-G-F mice, but not the 9-month old AppNL-F mice, we can infer some 
degree of association between Aβ deposition and DTI-derived neuropathology or, 
perhaps more accurately, the accumulative effects (e.g., inflammation, synapse loss 
etc.) of a more advanced stage of AD-pathology that is marked by the build of Aβ 
plaques. Thus, the soluble Aβ that is present in large quantities in the AppNL-F mice at 9-
months relative the age-matched wild-type control mice (Saito et al., 2014) does not 
appear sufficient to cause changes to the microstructural integrity of the neural regions 
we investigated. Understanding more precisely the reasons for the DTI-derived 
neuropathology in the 9-month old AppNL-G-F mice, contrasted with the lack of change 
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